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One of the most prevalent and important health problems in the world is periodontal 
and plaque-related diseases for which antibiotic drugs with their associated side effects 
are used as treatment. With increasing resistance to antibiotics and a desire from the 
general public for “natural” therapies, there is a need to minimize antibiotic use and 
develop new treatments for oral diseases without antimicrobial agents. Probiotics are 
viable microorganisms that provide a health benefit to the host when administered in 
adequate amounts; studies show that probiotics have the potential to modify the oral 
microbiota and decrease the colony-forming unit counts of the oral pathogens being 
investigated to prevent or treat oral diseases, such as dental caries and the periodontal 
diseases. In addition, the identification of specific strains with probiotic activity 
is required for any oral infectious disease to determine the exact dose, the time of 
treatment, and the ideal vehicle.
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Scope of the Series
Biochemistry, the study of chemical transformations occurring within living organ-
isms, impacts all of life sciences, from molecular crystallography and genetics, to 
ecology, medicine and population biology. Biochemistry studies macromolecules - 
proteins, nucleic acids, carbohydrates and lipids –their building blocks, structures, 
functions and interactions. Much of biochemistry is devoted to enzymes, proteins 
that catalyze chemical reactions, enzyme structures, mechanisms of action and 
their roles within cells. Biochemistry also studies small signaling molecules, co-
enzymes, inhibitors, vitamins and hormones, which play roles in the life process. 
Biochemical experimentation, besides coopting the methods of classical chemistry, 
e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron 
microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic 
tools, e.g., auxotroph mutants and their revertants, fermentation etc. More recently, 
biochemistry embraced the ‘big data’ omics systems.
Initial biochemical studies have been exclusively analytic: dissecting, purifying and 
examining individual components of a biological system; in exemplary words of 
Efraim Racker, (1913 –1991) “Don’t waste clean thinking on dirty enzymes.” Today 
however, biochemistry is becoming more agglomerative and comprehensive, setting 
out to integrate and describe fully a particular biological system. The ‘big data’ me-
tabolomics can define the complement of small molecules, e.g., in a soil or biofilm 
sample; proteomics can distinguish all the proteins comprising e.g., serum; metage-
nomics can identify all the genes in a complex environment e.g., bovine rumen. This 
Biochemistry Series will address both the current research on biomolecules, and the 
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Preface
In this book, the importance of using probiotics and probiotic foods in oral and oral 
health has been studied. The contents of the book include oral health and effective
factors, probiotic microarmonts, probiotic foods, probiotics and dental caries, 
probiotics, and oral fungal infections. The most suitable probiotic strains that
can be used in food and that are appropriate for the prevention of oral and dental 
problems are also discussed.
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factors, probiotic microarmonts, probiotic foods, probiotics and dental caries, 
 probiotics, and oral fungal infections. The most suitable probiotic strains that 
can be used in food and that are appropriate for the prevention of oral and dental 
problems are also discussed.
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Introductory Chapter: Oral Health 
by Using Probiotic Products
Razzagh Mahmoudi, Sara Moosazad, Katayoon Aghaei
1. Oral health
Oral health is one of the most important health issues and tooth decay raises a 
great deal of concern about that and with widespread public concern about the use of 
industrial drugs to reduce dental caries, nature-based treatments are highly wel-
comed. The second organ that has a diverse microbial community is the mouth, which 
contains more than 700 species of bacteria. Disruption of the natural microbial flora 
of the mouth through the consumption of various nutrients can have consequences 
for our health, such as oral and throat cancer, tooth loss, and periodontal disease [1].
2. Probiotic products
Many publications said using probiotic products can be a factor in improving the 
health of the digestive system, reproductive organs, and oral hygiene.
Probiotic bacteria should have the ability to adhere to and colonize surfaces in 
the oral cavity, have a good shelf life, and be nontoxic. Two main groups probiotic 
bacteria are Lactobacillus and Bifidobacterium. The Lactobacillus, as a member 
of oral microbial flora, can play an important role in the microcosm balance of 
the oral cavity. B. bifidum, B. longum, and B. infantis are the probiotic species of 
Bifidobacterium.
Today, with the increasing awareness of people about the beneficial effects of 
probiotic bacteria, consumption of functional foods is increasing. Functional foods 
are such food that promotes health [2, 3].
Functional foods must have three items:
1. they have a different effect from a nutrition standpoint;
2. they reduce the risk of pathological illnesses; and
3. they benefit the community and the consumer [4].
New food products are converted into probiotic foods by adding probiotic 
bacteria. These foods include a variety of different types such as cheese, ice cream, 
milk-based dessert, baby milk, and mayonnaise. The main thing is the texture of 
these foods [5].
The fourth mechanism of how probiotic bacteria work in the mouth include:
1. competition between probiotic bacteria and pathogenic bacteria in adhesion 
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2. they can produce factors such as peroxide and bacteriocin, which act as 
antibacterial agents against oral pathogens; and
3. with the presence of probiotic bacteria, oral conditions change and the growth 
medium of pathogenic bacteria do not occur, such as the reduction of pH or 
alteration of the structural protein of salivary glands [6, 7].
4. Probiotics can have beneficial effects on dental health by stimulating non-
specific immunity and regulating cellular and humoral immune responses.
3. Conclusion
Probiotics are becoming more common due to concerns about oral and dental 
diseases and increased consumer interest in natural remedies. Based on the research 
and the effect of probiotics in reducing the number of pathogenic bacteria in these 
organs, they can be used in foods.
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Therapeutic Potential of 
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Abstract
Advancement in technology is continued as the time is passed. The biological 
active ingredients technology is the challenging issues for both the researchers and 
manufacturers. In last decade, much research has been happened about the poten-
tial health benefits of pro and prebiotic ingredients. Probiotics are the live microor-
ganisms when given in adequate amount confer health benefits but the prebiotics 
are indigestible ingredients that enhance the activity of one or more probiotics in 
the colon. The therapeutic potential of these two biological active ingredients is the 
outcome of emerging field of biotechnology. A number of studies indicating thera-
peutic potential of probiotics regarding gastrointestinal health, cancer, constipa-
tion, immunomodulation, Helicobacter pylori, liver disease and urogenital infection 
have been documented. Similarly, prebiotics also improved helpful for many 
communicable and non-communicable diseases. It can be seen that advancement in 
the biotechnology field offer great choice to deliver a marvelous health advantages. 
Although the market for probiotic and prebiotic food and supplements has been 
increased in this new era but still need to develop food and supplements containing 
these two active ingredients with the cooperation of legal bodies of the country.
Keywords: therapeutic, probiotics, prebiotics
1. Introduction
This chapter criticizes and presents the role of different probiotics and prebiotics 
in the prevention of various ailments and improvement of consumer’s health. Scientist 
worked and explored the action of beneficial live microorganisms and non-digestible 
food components for the improvement of human health. The chapter highlights various 
sources and mode of action of probiotics and prebiotics. Disease prevention and health 
intriguing aspects of these therapeutic components is also addressed in this chapter.
2. Probiotics
The term probiotics was characterized by Parker [1] as life forms and some sub-
stances which are responsible for the equalization of the intestinal microorganisms. 
Fuller [2] defined probiotics as feed supplements in the form of live microorgan-
isms which valuably influences the host creature by enhancing the microbial bal-
ance in the intestines. Subsequently, Moriarty [3] recommended that the meaning 
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of probiotics be reached out to microbial water added substances. Administering 
probiotics in water has been appeared to enhance water quality by decreasing the 
centralizations of nitrogen and phosphorus [4]. Probiotics directed in water or 
eating routine likewise may hinder the development of pathogenic microorganisms, 
contribute stomach related proteins to expand feed usage, give other development 
advancing components, and restoring the immune response of the living beings.
Hill et al. [5] updated the probiotics as live microorganisms when given in 
adequate amount confer health benefits.
2.1 Probiotics: selection criteria
For the living organisms to be termed as probiotics the given criteria should be 
fulfilled:
1. It must get separated from the same species from its expected host.
2. It ought to have an clear favorable impact on its host.
3. It should not produce any symptoms of disease.
4. It ought to have the capacity to survive the conditions gastrointestinal tract and 
can easily be passed through it.
5. During storage, greater number of practical microscopic organisms must have 
the capacity to endure extended lengths of time [6, 7].
2.2 Probiotics: mechanism of action
Mechanisms for the advantages of probiotics are not completely understood. 
However, generally it includes [8].
• Adherence and colonization of the gut.
• Suppression of development or epithelial authoritative/intrusion by pathogenic 
microscopic organisms and generation of antimicrobial substances.
• Improvement of intestinal hindrance work.
• Controlled exchange of dietary antigens.
• Stimulation of host mucosal and systematic immunity [9].
2.3 Standardization of probiotics
In Europe health claims of probiotics are assessed by the “European Food Safety 
Authority” (EFSA). For the selection guidance of probiotics European Commission 
published probiotics health claims [10] this meant that probiotics are not consid-
ered as nutrition claim but it is a health claim. It is further clarified that this general 
health claim is not mention for any body functions because the health claim of 
probiotics and strain specific. Consequently, probiotics term is banned with regard 
to advertising and labelling as food supplement in Europe.
7
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In USA probiotic companies face legal encounters. In the research of probiotics, there 
are also FDA’s restrictions for human trials. The study with regard to human trial must 
be filed as “Investigative New Drug,” which appears redundant and costly obligation.
In Canada, the government has also issued regulatory documents for the use 
probiotics in food. Canada has a list of 17 probiotic species that can make nonspe-
cific health claims, but no strain-specific probiotic claims have been approved [11].
In 2012, the Chinese Food and Drug Administration (CFDA) issued 
“Requirements on and a Guide to the Naming of Health Foods” and this year, 
provision for health food registration and filing was released. Currently, there are 
27 health food categories based on health effects recognized in China, including 
enhancing immunity, the maintenance and relief of constipation, and modulating 
the intestinal bacteria. The health claim of any probiotics are governed an approval 
process involving technical review of safety, scientific substantiation of the health 
effect (based on animal and/or human studies), quality control, quantitative assess-
ment and assessment of the product formulation [12].
2.4 Commonly used probiotics
A portion of the widely utilized probiotic microorganisms are Lactobacillus 
rhamnosus, Lactobacillus reuteri, bifidobacteria and certain strains of Lactobacillus 
casei, Lactobacillus acidophilus-groups, Bacillus coagulans, Escherichia coli strain 
Nissle 1917, certain enterococci, particularly Enterococcus faecium (SF68), and the 
yeast Saccharomyces boulardii. Bacterial spore formers, for the most part of the class 
Bacillus influence the scene. The given probiotics are being used in variety of food 
products such as fermented milks either independently or in mixes. With the new 
research endeavors new genera and strains of probiotics are being developed.
Probiotic can either include a single stain or a blend of at least two strains. For 
example, VSL3 is a probiotic that comprises of blend of eight different strains. The 
effects of probiotics are strain specific and cannot be summed up. A one strain may 
display diverse advantages when utilized exclusively and in mix. The benefits aris-
ing from the use of probiotics vary according to patient group. Constrained studies 
showed the adequacy of use of multiple probiotic strains [13].
FAO and WHO have mutually introduced advanced rules with a specific end 
goal to establish the systematic outlook for a successful Probiotic assessment 
probiotics in nourishments to support the health cases and other advantages. The 
standard rules on probiotics developed by FAO/WHO could be used worldwide for 
assessing probiotics in nourishment that can lead to the supporting of health claims. 
According to the rules following activities must be fulfilled:
1. Identification of strain.
2. Functional portrayal of the strains and safety properties.
3. Proving the medical advantages in human examinations.
4. Labeling of the adequacy claims and the shelf life of the substance must be 
honest and should not be deceiving.
2.5 Therapeutic potential of probiotics
The probiotics have most imperative and recorded helpful impacts that incor-
porate the prevention from various diseases including diarrhea, increasing the 
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Oral Health by Using Probiotic Products
8
effectiveness of antibacterial activity, reduction in the symptoms of constipation, 
changes in the conjugation of bile and salts. Moreover, they are also involved in 
nutrient formation and in enhancing their utilization by the body; a few probiotics 
are thought to have anti-oxidant action as entire cells or lysates. Probiotics have 
additionally exhibited their intrinsic impacts in reducing manifestations of allergy, 
cancer AIDS, various infections of respiratory system and urinary tract. There are 
different random reports on their advantageous impacts on autism, fatigue, type 2 
diabetes, aging, fatigue, obesity and osteoporosis [14].
2.5.1 Diarrhea
The Diarrhea is defined by World health Organization as three to four watery 
stools in the period of 24 hours. Over the period of more than 20 years several 
examinations have been done on the microorganisms by several in vitro studies, 
animal models and some other suitable clinical investigations have confirmed 
the role of probiotics in reducing the severity of various type of diarrhea [15] 
Saccharomyces boulardii is the only yeast probiotic that is used for treating the 
diarrhea.
2.5.1.1 Acute infantile diarrhea
Rotavirus is the major cause of acute infantile diarrhea and is the most con-
centrated gastrointestinal condition and it requires quick oral rehydration as 
an essential treatment. Along with the oral rehydration therapy Probiotics are 
thought to have beneficial effects. Although further data is needed to confirm the 
investigations however 10 billion CFU is the minimum potent dose in kids within 
the 48 hours [16]. A trial was conducted on C. difficile-related colitis and results 
showed that S. boulardii reduce the onset of infection in the patients who had more 
than one consecutive C. defficile disease. S. boulardii is yeast which produces prote-
ases that inhibit the C. defficile toxins and also blocks its receptors in the intestines. 
The yeast S. boulardii discharges a protease that separates C. difficile poisons and 
hinders the poison intestinal receptors. The Probiotic additionally found to activate 
particular antitoxin A which is an immunoglobulin that attacks the factor involved 
in increasing the risk of diarrhea [17, 18].
2.5.1.2 Antibiotic associated diarrhea
Disruption of the natural micro flora is due to the use of anti-microbial medica-
tions, i.e., antibiotics frequently prompts diarrhea. The principle component by 
which antimicrobials cause loose bowels is through weakened protection against 
pathogens because of disruption of gut micro flora and as a result there is a modi-
fication in the digestion of sugars bile acids and unsaturated fatty acids resulting 
modifications in the digestion of sugars, short-chain unsaturated fats, and bile acids 
[19]. Probiotics are more powerful in reducing the onset of diarrhea as a result of 
use of antibiotic medications and these includes strains of L. acidophilus, yeast S. 
boulardii, L. delbrueckii, L. rhamnosus GG, L. fermentum, etc. [18]. However, further 
studies are needed to confirm the beneficial role of probiotics in various diseases, 
which probiotic is more potent and their recommended dosages [20].
2.5.1.3 Traveler’s diarrhea
It has been assessed that around 20–60% of the people traveling around the 
world are affected by this type of diarrhea. It especially influences individuals those 
9
Therapeutic Potential of Probiotics and Prebiotics
DOI: http://dx.doi.org/10.5772/intechopen.86762
who travel from the developed or industrialized areas to the backward or remote 
areas, specifically traveling between tropical regions and other non-tropical areas. 
The major cases that are recognized are due to the microscopic organisms which 
accounts for approximately 60–85% of the cases and most causative bacteria for 
causing this is E. coli and Compylobacter jejuni and some other species of Salmonella 
and Shigella disease is also caused by parasites and viruses which accounts for 
around 10% and 5% toward causing the infection [21]. It was observed that the bac-
teria that was effective against Bacterial diarrhea is S. boulardii whereas the activity 
of Lactobacillus GG was observed to be more potent against diarrhea caused by the 
virus and the idiopathic diarrhea [22–24]. Bacterial Strains that are thought to have 
preventive effect on the traveler’s diarrhea include the Bifidobacteria, Lactobacilli, 
and Streptococci and Enterococci [18].
2.5.2 Inflammatory bowel disorder (IBD)
IBD is a long term degenerative disease which involves the severe irritation of G.I.T 
tract that leads of watery and bloody diarrhea along with the abdominal pain IBD 
affects the small intestines and a portion of large intestines that is colon and it includes 
three different conditions which are Crohn’s disease, ulcerative colitis (UC) and pou-
chitis. The other factors that are associated with the onset of disease include the genetic 
factors, ecological factors, oxidative stress and the weakened immune system [25].
Crohn’s disease and ulcerative colitis are long term diseases of the gastro-intes-
tinal tracts that are associated with the inflammation of the immune and likely are 
because there is absence of balance of the natural immunity with the surroundings 
and the with the advancement of the culture [26]. Intake of probiotic bacteria can 
possibly balance out the immunological boundary in the gut mucosa by diminish-
ing the production of nearby proinflammatory cytokines [27–29]. Bifidobacterium 
infantis 35,624 helps in elevating the symptoms of abdominal pain, bloating, passage 
of gas, straining, bowel dysfunction and incomplete evacuation in the patients of 
IBD. It has been observed through recent studies that Probiotic supplementation is 
very helpful in elevating the symptoms of IBD and in some cases even the medical 
therapy can be replaced by probiotic supplementation. However it is not recom-
mended for the Crohn’s disease as the data does not support the use of probiotics. 
Therefore Probiotics have shown promising role in reducing the symptoms of 
ulcerative colitis but not in the case of Crohn’s disease [30].
2.5.3 Ulcerative colitis (UC)
Ulcerative colitis like Irritable bowel disorder fundamentally influences the 
inner layer of the rectum and that of large intestines. Long-term ulcerative colitis 
can lead to the development of colon cancer. Use of different probiotics including 
S. boulardii, L. casei, Bifidobacterium bifidum has demonstrated beneficial results in 
terms of this disease [31]. A Study was conducted and the results demonstrated that 
the addition of probiotics bacterial strains of L. acidophilus, B. bifidum, and B. breve 
in the fermented milks was helpful in mitigating the diseases in patients [32].
2.5.4 Crohn’s disease (CD)
It is a type of Irritable bowel syndrome which ordinarily influences the digestive 
system; however it may affect any organ from the mouth to the end of the end of 
digestive tract. Crohn’s disease leads to the development of the ulcers and irrita-
tion that influences the capacity of the body to process food, assimilate nutrients 
and excretion of unwanted products in a healthful form. The Bacterial strains that 
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are involved in causing Crohn’s disease include Salmonella, Clostridium difficile, 
Campylobacter jejuni, Mycoplasma and Adenovirus, There are various reports that 
influence the efficacy of various probiotics, e.g., S. boulardii, L. GG, VSL3, E. coli 
Nissel 1917, in combating the issues of CD in human beings [33].
The role of probiotics in therapeutic utilization of Crohn’s disease is because of 
its competition with the groups of bacteria, maintaining the immune system and 
also destroying the various pathogenic microorganisms. Irritable bowel syndrome 
can additionally be prevented by using the probiotics which help in maintaining the 
defensive functions of the mucosa of intestines [34].
2.5.5 Pouchitis
Pouchitis is third kind of Irritable bowel syndrome where there is inflammation 
of ileal pouch particularly after the procedures such as colectomy and the other 
include anastomosis of ileal pouch. Various Studies were done and it was observed 
that the blend of probiotic VSL3 plays a significant role in the reduction of this 
disease [35].
The strains of powerful probiotic stimulate definite IL-10 and IL-4 mucosal cyto-
kine. Also Probiotics may impact the cell to cell association of mucosa and integrity 
of the cells through upgrading activity of intestinal mucosa through the regulation 
of phosphorylation and cytoskeletal activity of tight junctional protein and further-
more through the production of enzymes having anti-oxidant nature. For example, 
catalase and superoxide dismutase hence remediating the symptoms of IBD [36].
Ileal pouch-anal anastomosis (IPAA) is the favored option to proctocolectomy 
with perpetual ileostomy in ulcerative colitis and the inherited disease in which 
adenomatous polyps are formed in the epithelial of large intestines. The most as 
often as possible noticed chronic problem of IPAA is potentially perpetual inflam-
mation of the ileal supply which is either acute or chronic and is called pouchitis. 
Gionchetti et al. in a randomized, controlled treatment containing placebo pre-
liminary in which VSL3 was regulated to 40 patients quickly after carefully surgi-
cal formation of ileal anal pouches, accomplished abeyance of 90% in the group 
treated with VSL3 versus 60% in the placebo treatment group following a year 
[37]. These examinations have confirmed the role of VSL3 in the administration of 
pouchitis [38].
According to the Rome II Crieteria irritable bowel syndrome is defined as 
syndrome that lasts for greater than 3 months with the implications of either 
diarrhea or constipation and also accompanied by the abdominal pain. Many 
studies on the role of probiotics in preventing Irritable bowel syndrome have 
been conducted [39–43]. Out of five surveys conducted three trials showed 
a decrease trend in the symptoms of Irritable Bowel Syndrome. As there is a 
beneficial role of the probiotics but the reduction in the symptoms of disease 
without the clinical manifestations has not yet confirmed. However, beneficial 
role of probiotics in terms of clinical improvement can be attained in reduc-
ing the symptoms related to the diarrhea. Many new studies are needed to be 
conducted on variety of bacterial strains to draw any conclusion regarding their 
beneficial role [44].
2.5.6 Lactose intolerance
It is a type of disorder that comprises of intolerance to the digestion of carbohy-
drate lactose that is present mainly in dairy products having prevalence of around 
7–20% in Caucasians, 90–100% in Asians and from around 50–85% in Africans 
[45]. Lactose intolerance can be solved by using the probiotics that alleviate 
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the symptoms by reducing the transit time through gastro-intestinal tract [46]. 
Probiotics such as Streptococcus thermophilus and Lactobacillus bulgaricus undergo 
the process of fermentation and as a result produces an enzyme lactase that helps in 
the breakdown of lactose into its subunit glucose and galactose. Thus, it is suggested 
that the intake of probiotics can help in the digestion of lactose inside the gut lumen 
and reducing the symptoms of lactose intolerance in both children and adults [47].
2.5.7 Colon cancer
The intake of probiotics and prebiotics has several antagonistic effects on muta-
gens [48, 49]. The link between the colon cancer and diets that are high in fats and 
oils and low in fiber and some other western diets lead to the alteration in the bacte-
rial enzymes in the feces. The process through which the probiotic bacteria such as 
lactobacilli reduce the onset of colon cancer may include various modifications on 
the metabolic pathways of the intestinal microflora, inhibiting and binding of the 
cancer causing agents, physicochemical alterations in binding to colon, formation 
of compounds cancer causing agents and several other mutagens. Improving the 
immune system and physiology of the host. There is a remarkable evidence on the 
basis of various animal models and controlled studies [50, 51]. However, there is not 
enough data or studies to confirm the role of probiotics for protection against the 
onset of colon cancer.
The process through which the probiotics exhibit tumor suppressing activity 
includes the modification in the immune functions that are related with the vari-
ous immune responses, Regulating cell differentiation and apoptosis, inhibiting 
the formation of the enzymes produced from the pathogenic bacteria E. coli and C. 
perferinges that includes the ureases different reductases specifically nitroreductases 
and oxidoreductases, β-glucuronidase and choloylglycine hydrolase. Enzymes such 
as ureases and beta glucosidases are involved in the conversion of pro carcinogens to 
the active carcinogens. In a study probiotic namely Propionibacterium freudenreichii 
produced Short chain fatty acids in the culture media and caused the cell death of 
gastric and colon cancer cells in humans [52, 53].
2.5.8 Constipation
It is common problem among the older population. Several controlled studies 
showed that in constipation either the bowel movements are increased or there is 
decrease in the transit time through the gastro-intestinal tract, for this purpose 
probiotics are utilized in the treatment of constipation [54, 55]. The most frequently 
used laxative is lactulose which is also a probiotics is not affected by the disacchari-
dases of the humans and the microflora in the colon, bifidobacterium utilizes it as a 
substrate that breakdown it into the smaller subunits leading to the creation of the 
osmotic effect. However, larger controlled studies are needed in order to confirm 
the use of prebiotics and probiotics apart from lactulose [56, 57].
2.5.9 Immunomodulation
Probiotics are involved in the modulation of the immune responses, are anti-
inflammatory in nature and also have effect on humoral and cell regulated immu-
nity. Probiotics are thought to involve in secretion of the factors that are responsible 
for regulating the immunity. For example the factors secreted from the probiotic 
strain L. reuteri limit the gene expression that is dependent on NF-Κb which results 
in the decrease in cell growth and greater protein kinases activated by nitrogen 
which leads to the induction of apoptosis [58].
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Probiotics are present in greater quantity in fermented milks. During milk fer-
mentation, L. helveticus is able to produce factors that are involved in enhancing the 
expression of calcineurin which is involved in the formation of mast and goblet cells 
in the gastrointestinal tract of mouse [59]. The intake of probiotic strain VSL3 is 
involved in down regulation of such immune responses by decreasing the secretion 
of IL-8, regardless of the presence of the bacterial pathogen Salmonella dublin [60].
2.5.10 Helicobacter pylori
The most common and worst bacterial infection found in human is the 
Helicobacter pylori. It causes a number of diseases like peptic ulcers, chronic gastri-
tis, lymphoma, gastric adenocarcinoma and number of other diseases not related 
to gastrointestinal tract. Probiotics prevent the H. pylori infection by enhancing 
the immunoregulation functions that works as antagonistic to infection caused by 
H. pylori [61–63]. Many studies reported that H. pylori growth and gastritis infec-
tion can be minimized but the causative organism cannot be completely removed. 
It is noted that prebiotics plays their role for the suppression of H. pylori as well as 
they also enhance the efficacy of eradication therapy by stopping the side effects 
caused by antibiotics thus improving compliance [64]. saccharomyces boulardii is 
found helpful in reducing the symptoms of Helicobacter pylori.
2.5.11 Liver disease
2.5.11.1 Hepatic encephalopathy
By changing the microbiota count in the gut either by using probiotics or 
fermentable fiber has been related for the treatment of hepatic encephalopathy in 
experimental studies [65, 66]. This therapy works as it lowers the blood ammonia 
level due to inhabitation of bacteria that is acid resistant as well as not producing 
urease Further work on this approach is still under work [67].
2.5.11.2 Nonalcoholic fatty liver disease
Nonalcoholic steatohepatitis is a disease in which patients are not edict of alcohol 
but showing the systems of liver biopsy. Experiments on model rats suffering from 
fatty liver disease have been indicated that intestinal microbiota, bacterial endo-
toxin and tumor necrosis factor α modulate liver damage caused by alcohol. There is 
a perception that intestinal microbiota produces endogenous signals, which shows a 
pathologic role in nonalcoholic fatty liver disease, suggests a role for novel probiotic 
therapy in this not so uncommon condition [68, 69]. Recent studies have showed 
that nonalcoholic fatty liver disease is also thought to be linked with the dysbiosis 
of gut microbiota. By restoring and maintaining the gut microbiota, nonalcoholic 
fatty liver disease can be controlled. However extensive studies on the strains of gut 
microbiota and tests on various probiotics may be helpful in determining the use of 
specific probiotic for this disease [70].
2.5.12 Probiotics in infants health
Human milk defends infants from contagious diseases by several mechanisms. 
Human milk has various components that modulate the intestinal microbiota 
and bifidobacteria. These bacteria are the basic and significant constituent of the 
infants that are fed with human milk [71, 72]. Human milk can also minimize the 
incidence and harmful effects of inhabiting pathogens [73, 74]. Consequently, 
13
Therapeutic Potential of Probiotics and Prebiotics
DOI: http://dx.doi.org/10.5772/intechopen.86762
it has been observed that a balanced increased in bifidobacterial concentration 
and reduction in enteric bacterial count and luminal factors of host may show a 
positive role in defending premature offspring and infants from diarrheal disease. 
Alteration of the intestinal microbiota by improving the prevalence of nonpatho-
genic bacteria is an effective method to attain a therapeutic treatment against 
enteric pathogens [75].
2.5.13 Urogenital infections and HIV
Various urinary tract infections like yeast vaginitis, Bacterial vaginosis and 
frequent urinary tract infections are major problems faced by the patients. In 
premenopausal women normal microflora consist of lactobacilli that protect host 
from infections but various patho-physiologic causes can results infection due to 
unstable microflora. A very few studies that reports the importance of probiotics 
for urogenital health [76, 77]. The awesome practices have reported that L. aci-
dophilus has positive effect in urogenital health. Promising studies showed evidence 
that probiotics are also important in preventing recurrent urinary tract infection in 
women [78]. The women suffering from human immunodeficiency virus infection, 
prevention of bacterial vaginosis is very important. Previous literature indicates 
that women that have improper balance of lactobacilli (vaginosis) are in a great risk 
of human immunodeficiency syndrome [79, 80]. Therefore an adequate level of 
lactobacilli and preventing bacterial vaginosis is a best method to reduce the risk of 
getting human immunodeficiency virus infection, gonorrhea and trichomoniasis. 
One of the recent study shown that a probiotic strain (Lactobacillus reuteri RC-14) 
specific for human vagina can give strong protection from virus that can reduce 
the transmission of sexual immunodeficiency virus infection. Still, further work 
is required to approve these results before the extensive use of probiotics for the 
treatment of these diseases can be suggested [81].
2.5.14 Breast cancer
Several studies have been conducted on animal and human models to check the 
effect of probiotics in breast cancer. Several in vitro studies have shown that probi-
otics are involved in reducing the tumor size and stopped the growth of tumour. In 
Human studies it was observed that the use of probiotic Lactobacillus casei shirota 
prevented the onset of breast cancer. Also the use of fermented dairy products such 
as yogurt and fermented milk was inversely linked with the onset of breast cancer. 
Probiotics can be used for both preventive and treatment purposes of breast cancer. 
However more studies are needed in order to confirm the safety and efficacy of 
probiotics in breast cancer [82].
2.5.15 Type 2 diabetes mellitus
Experiments have shown that Type 2 Diabetes Mellitus can be result of dysbiosis 
of gut microbiota. This microbiota is involved in the permeability of gut mucosa 
and immune system of host which are linked to the type 2 diabetes mellitus. 
Different type of probiotic strains either single or multiple can be used for interven-
ing type 2 diabetes mellitus. Probiotics that are mainly used to treat the symptoms 
of type 2 diabetes are Lactococcus, Bifidobacterium and Lactobacillus. After the 
oral probiotic administration can be helpful in modulating the immune function, 
gut microbiota and balancing the energy metabolism. Therefore it was suggested 
that probiotics are involved in reducing the incidence, delaying and reversing the 
complications of Type 2 diabetes [83].
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3. Meat and dairy products as a functional agent
3.1 Dairy Products
Authors have considered different traditional dairy products such as yogurt, 
milk and cheese as a functional products as these are rich source of various vitamins 
and minerals and other constituents that can be used as functional agents [84]. 
Such as conjugated linoleic acid (CLA) and Selenium, that play an important role in 
lowering the serum cholesterol level thus preventing the atherosclerosis and other 
cardiovascular diseases also having antioxidant functions in the body [85].
Yogurt is a traditional dairy product that was prescribed by physicians in Middle 
East as a treatment of gastrointestinal diseases [86]. Yogurt is manufactured 
using Streptococcus thermophilus and Lactobacillus bulgaricus which both work in 
synergism. Health benefits of yogurt can be enhanced by the addition of probiotic 
bacteria in yogurt such as Bifidobacterium, Lactobacillus acidophilus and L. rham-
nosus [87]. Yogurt has been used a food source consisting of probiotic organism 
throughout the world.
A wide variety of fermented milks have also been developed and various health 
benefits were linked with the consumption of fermented milks such as lowering of 
cholesterol. They also contain the important probiotics strains that are involved in 
improving the health [88].
Probiotic cheeses are available in soft as well as hard varieties. Various Probiotic 
Strains such as Bifidobacterium and L. rhamnosus are readily used in such cheeses 
and these cheeses can be beneficial source of Probiotics [89].
3.2 Meat products
Meat products are good source of protein and fat along with water and other 
vitamins which are highly bioavailable. Meat products can be made highly 
beneficial for health either by incorporating any ingredient in it that is consid-
ered healthy or eliminating or reducing any component that can be considered 
harmful [90].
Fatty acid and cholesterol level of meat can be modified by selecting different 
breeds, modifying the feed patterns, addition of some feed additives and several 
interventions regarding animal metabolism [91].
Similarly addition of olive oil to variety of meat products was thought to be 
associated with the high biological value and decrease onset of breast cancer and 
heart diseases [92].
Soy protein can also be added into the meat products. In 1999, US FDA stated 
that any product low in saturated fats and cholesterol containing 25 g of soy pro-
teins may be helpful in preventing the cardiovascular diseases [93].
Lipid oxidation is the major issue in meat products thus instead of using syn-
thetic antioxidants that pose toxicity and other harmful effects can be replaced 
by the antioxidants from the plat source such as rosemary, tea, etc. Green tea is 
associated with reducing the level of Cholesterol in body as well as increasing the 
portion of High density Lipoproteins and decreased the oxidation of lipoproteins 
[90, 94, 95].
Addition of salt for the preservation purpose can lead to high percentage of salt 
intake and can lead to the development of hypertension. Several substitutes were 
assessed and one of the best substitute was the addition of calcium ascorbate. This 
substitute causes higher acidification due to the fermentation by lactic acid bacteria. 
Replacement of salt with Calcium ascorbate helped in reducing the sodium chloride 
level as well enriching the meat with nutrition [96].
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4. Prebiotics
Prebiotics are the food that is not digested in the human gut but food ingredients 
boost the growth and activity of bacteria that are good for our intestine, conse-
quently they balance the intestine of an organism [97]. The most commonly used 
bacteria that are good for our health is amplified by prebiotics comprise of genus 
Bifidobacterium and Lactobacillus, which control the growth of harmful bacteria. 
Most commonly used prebiotics are mannan-oligosaccharides, galactoglucoman-
nans, lactose, inulin and oligofructose. Short chain carbohydrates used as prebiotics 
consist of three to ten sugar units derived from the cell wall of yeast and plants. 
Prebiotics functionality are not alter by any food processing treatment and require 
little or no regulatory requirements, hence making their consumption more easy as 
compare to chemical treatment.
4.1 Mode of action of prebiotics
Important modes of action of prebiotics are:
• These are non-digestible carbohydrates that are not digested by the upper gas-
trointestinal tract and travel in the ileum and colon where fermented by the 
resident microbes.
• Prebiotics do cause intestinal homeostasis.
• Host surface receptors are coated by prebiotics.
• They produce bateriocins.
• Favorable bacteria produce short chain fatty acids with the help of non- digestible 
carbohydrates.
• Short-chain fatty acids are the energy source of epithelial cells.
• They regulate metabolic function and modulate immune system [98].
4.2 Targets for prebiotics: gut microbiota and intestinal health
Fermentation of resistant starches and dietary fiber caused by bacteria in colon 
release short chain fatty acid metabolites (SCFA). SCFA are well known for gut 
health as well as their part in provision of supplementary energy to the host in 
fatness is in debate. On contrary, 10% of entire energy in humans is provided by 
SCFA. According to energy yield hypothesis, dysbioticmicrobiomes have an ampli-
fied capacity to remove energy from the food, so that the bacterial conversion of 
non-digestible carbohydrates and dietary fiber to SCFAs could give additional 
energy to the host and result fatness of individual over time. Likewise, G-protein 
coupled receptors (GPR) can sense SCFAs that tie them with lipid and glucose 
breakdown. SCFAs activate the two major proteins, GPR41 and GPR43 which are 
expressed on adipocytes and enter endocrine L cells. Peptide YY is released by 
stimulation of intestinal GPR41 which enhances gut passage time and increase sati-
ety. Inflammation lessens by activation of intestinal GPR43 as well as it simulates 
glucagon-like peptide (GLP), a hormone which contributes in regulation of insulin 
secretion. Enteroendocrine L cells express GLP-1 as well as secrete the gut-trophic 
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hormone GLP-2. Chief stimulus for GLP-2 secretion is nutrient consumption. 
SCFAs maintain the release of GLP-2 which is important in regulation of the gut 
fence system and decreases lipopolysaccharide translocation [99].
4.3 Healthy diet for probiotic
4.3.1 Dietary fiber
Diet is an element on which unequal antagonism exists between the microflora 
of gut and specific group of bacteria get their nutrition. It also serve as direct 
medium for the gut microflora since it may act as a direct substrate for the microbi-
ota through its indigestible constituents and some by-products of digestion. Among 
all the nutritional constituents, dietary fibers are vital as they cannot be absorbed in 
the upper part of the digestive system; although they can be fermented in the lower 
part of the gut by the intestinal microbiota [100].
4.3.2 Prebiotics
Prebiotics are a subcategory of nutritional fibers that is not affected by the 
gastric acidity and the enzymes present in the digestive system of mammals which 
is very crucial for our health [101]. The main distinguishing benefit of prebiotics 
is their stimulation in growth of intestinal bacteria connected with fitness and 
comfort [102].
4.3.3 Complex carbohydrate
Some complex carbohydrates include resistant starch and plant cell-wall poly-
saccharides are not digested by the gut microflora. Polysaccharides comprising of 
cellulose, hemicelluloses (xylan, xyloglucan, mannan, β-glucan) and pectin. These 
all complex carbohydrates have positive simulative effect on microbial populations 
in the gut [103]. A number of bacteria present in human gut that possess genes 
programming with carbohydrate-active enzymes (CAZymes) in their genomes. 
These bacteria can digest such compound carbohydrates.
4.3.4 Prebiotic carbohydrates
Prebiotics definition is fulfilled by resistant starch [101]. In the colon prebiotic 
type of fermentation is provided by it and has lots of metabolic advantages, for 
instance it increase the bile salt production and laxation, lowers the danger of 
gastrointestinal tract cancers, and lowers the after meal glucose stimulus and blood 
lipid levels [104, 105]. Farther more it assists in growing of epithelial cells and 
propagation by increased butyrate concentration via its fermentation by the gut 
microbiota [106].
4.3.5 Algal (AGAL) polysaccharides
AGAL polysaccharide provides with dietary fiber, e.g., alginates, agars and 
carrageenan from seaweeds, consumed in food industry as thickeners and stabiliz-
ers or emulsifiers [107]. Many health benefits provided by dietary fibers due to 
its gel-forming ability and other physicochemical properties, including ability to 
ferment by the alimentary canal microbiota [108]. These benefits include controlled 
appetite, type 2 diabetes and obesity by increasing satiation, refining of gut barrier 
working and lessening the ad worse effects of luminal components.
17
Therapeutic Potential of Probiotics and Prebiotics
DOI: http://dx.doi.org/10.5772/intechopen.86762
Gut bacteria cause fermentation of compound carbohydrates that has ben-
eficial affect for the host. This activity makes complex carbohydrate as potential 
prebiotics. Proteolytic activity produce potential harmful product and the 
fermentation of complex carbohydrates reduce risk caused by these harmful 
metabolites [109]. Furthermore, some useful metabolites with anti-cancer and 
anti-inflammatory activities, like phenolic substances and short chain fatty acids 
are also produced by the microbial fermentation of complex carbohydrates in the 
gut [110].
Chemically, inulin-type fructans are a linear polydisperse carbohydrate 
material consisting mainly, if not exclusively, of β-(2–1)-fructosyl-fructose gly-
cosidic bond linkages [81]. Fructans are proposed to be classified as “functional 
fiber” according to recent concepts drawn from physiological effects on human 
individuals [111].
Guar galactomannan was enzymatically hydrolyzed to obtain partially hydro-
lyzed guar gum which can be utilized as prebiotic source. Partially hydrolyzed guar 
can be considered as potential prebiotic compound that may further stimulate the 
growth of potentially probiotic bacteria or native gut microflora [112].
4.3.6 Herbal prebiotics
Some herbs are used for the treatment of inflammatory immune diseases that 
also have prebiotic effect in the host. These herbs include Ocimum sanctum, Piper 
nigrum and Zingiber officinale. Zingiber officinale and Ocimum sanctum exhibited 
greater prebiotic activity, with higher growth of Lactobacillus and Bifidobacterium 
as compare to most commonly used prebiotic, fructo-oligosaccharide (FOS). 
However, Piper nigrum have similar prebiotic activity as that of most commonly 
used prebiotic FOS. These herbs used to regulate gut microbiota which ultimately 
prevent systemic swelling and related disorders [113].
4.3.7 Fractionated lotus seed resistance starch
Fractionated lotus seed resistance starch (LRS3) was fractionated and tested for 
its structural properties and prebiotic activities. LRS3–20% showed higher pre-
biotic activity against these bacteria Bifidobacterium adolescentis and Lactobacillus 
acidophilus as compared to LRS3–30% and high concentration of amylose maize 
starch [114].
4.3.8 Cereal grain fraction
Most commonly used cereal grains to develop new classes of prebiotic are corn, 
rice, wheat, barley and oats which also have high economic value [115].
4.3.9 Burdock root
It is rich source of fructo-oligosaccharides and phenolic compound but its use 
in food products are limited. It is widely used in bakery product for consumers that 
search for functional foods of health benefits. Burdock roots are effective alterna-
tive for functional foods with health benefits [116].
4.3.10 Lentil
Lentil food are rich source of prebiotic carbohydrates which have raffinose fam-
ily oligosaccharides, fructooligosaccharides, sugar alcohols and resistance starch.
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Gut bacteria cause fermentation of compound carbohydrates that has ben-
eficial affect for the host. This activity makes complex carbohydrate as potential 
prebiotics. Proteolytic activity produce potential harmful product and the 
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are also produced by the microbial fermentation of complex carbohydrates in the 
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biotic activity against these bacteria Bifidobacterium adolescentis and Lactobacillus 
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4.4 Therapeutic potential of prebiotics
4.4.1 Prebiotic impact on intestinal micro flora
Dietary fibers which are part of prebiotic play positive impact on intestinal micro 
flora [117]. In cholesterol metabolism prebiotic fibers play a very unique action specifi-
cally on fermentation of products and modulation of micro flora. Some research show 
both probiotics and prebiotics (in which non digestible food ingredients are more benefi-
cial for host which stimulate the growth of colonic bacteria) to suppress tumor and pre-
neoplastic lesions in the colons of animal treated with carcinogenic chemicals [118]. The 
presence of beneficial bacteria in gut of infants fed with human breast milk is supported 
by the metabolism of the complex mixture of oligo saccharides present in the milk. More 
mature gut microbiota is found in the formula milk. In adults formulation infants is used 
to achieve a type of intestinal microbiota. Improper gut microbiota (dysbiosis) can cause 
autoimmune disorders, infections and allergic reactions in old age [59].
4.4.2 Colon cancer and prebiotics
Aberrant crypt foci (ACF) is the first detectable abnormal growth of cells 
appears as lesions in the large intestine. To identify ACF lesions chromoscopic 
colonoscopy of high magnification is used, generally it appear as colonic mucosa. 
They comprised of crypts that are raised on upper side of normal mucosa. It 
consists of extremely condensed epithelia and has changed luminal openings visibly 
confined from the normal neighboring crypts. The development of the ACF to 
polyp, adenoma and adenocarcinoma equivalents buildup of numerous genetic and 
biochemical modifications. A little amount of ACF can be a cause of colon cancer. 
Presently, it is unidentified that which crypts are responsible for the development 
of tumor. Though, various researches support the idea of development of colon 
cancer from ACF [119]. Perrin et al. [120] reported that some fibers which stimulate 
the formation of stable butyrate-producing colonic ecosystem. This type of colonic 
environment diminished the rate of ACF. Therefore it is clear that colonic ecosystem 
that produces stable butyrate decreases the risks of developing colon cancer.
4.4.3 Prebiotics modulation of immune function
Immunological functions are modulated by our diet and affect resistance of host 
by various ways. Along with essential food components non-essential nutrients like 
non-digested carbohydrates also play an important role in controlling the immuno-
logical responses, particularly lymphoid tissues of the gut. Bodera [121] reviewed 
the previous literature by various scientist on the effects of prebiotics in enhancing 
the immunity of host and observed that there is sufficient proof indicating prebiot-
ics such as inulin helps in the modulation of immunological functions. He suggests 
to take prebiotics for the modulation of immunological parameters in gut associated 
lymphoid tissues, secondary lymphoid tissues and peripheral circulation. First line 
defense is provided by the innate immune system and prevent the entry of conta-
gious agents or eradicating entering pathogens. It encompasses physical fences like 
skin and mucous membranes, blood cells and tissue, such as phagocytes, natural 
killer cells and soluble mediators, like supplement proteins and cytokines.
4.4.4 Prebiotics as dietary modulators of gut microbiota in obesity
It is suggested that gut microbiota plays an important role in obesity and obesity-
associated comorbidities that gut microbiota could be a possible goal for fatness 
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involvements. It is assumed that microbial dysbiosis is associated with fatness, it 
is concluded that restoring the potential symbiosis between the gut microbiota 
and host holds great potential. Prebiotics are consumed so that gut microbiota can 
be modified. Prebiotics are not capable to be digested by host enzymes although 
they move in the large intestine and are particularly fermented in the gastrointes-
tinal tract where they help in growth of bacteria particularly Bifidobacterium and 
Lactobacillus that have been related with health benefits [122].
4.4.5 Prebiotics assist in the management of cognition
Worldwide, Schizophrenia is the 25 leading cause of disabilities that decrease 
the life about 10–20 years. Inappropriate treatment like pharmacotherapy in the 
administration of cognitive defects and weight gain are recognized a significant 
contributors of these diseases; therefore there is a need to develop such treatments 
that alleviate one, or both, of these diseases would be very helpful. By using gut 
microbiome from dietary source like prebiotics for the treatment of these diseases 
may be one such intervention. Moreover, prebiotics also effect breakdown, and 
in case of obesity they rise the concentration of anorexigenic gut hormones such 
as peptide tyrosine tyrosine, glucagon-like peptide 1 and leptin and decrease the 
amount of orexigenic hormones such as ghrelin [123].
4.4.6 Prebiotics for the improvement of enzyme activity and phosphate uptake
Prebiotics improve the activity of enzymes and phosphate uptake in the intes-
tine. One of study was conducted to recognize the impact of prebiotics supple-
mentation in infant formula on enzyme activity and phosphate uptake in the small 
intestine of Sprague Dawley (SD) rats. Forty-eight fifteen days old SD rats of similar 
weight were divided into three groups randomly: A was selected as control group in 
which SD rats were fed with standard infant formula with no prebiotics treatment. 
Rats in groups B, C were nourished standard infant formula supplemented with 
oligosaccharides, and the standard infant formula supplemented with polysac-
charides, correspondingly. The results were checked at 28 days. It was observed that 
as compared to group A, group B and C showed the following: (1) In SD rats group 
C showed greater activities of sucrose and lactase in the small intestine; (2) In SD 
rats of group C comparative expressions of lactase gene in the anterior and posterior 
segments of the small intestine were increased by 1.68 and 2.26, and the Mgam gene 
relative expression in the posterior segment of the small intestine was improved 
by 0.99 in SD rats of group C; (3) the relative expressions of Na/Pi-IIb gene in 
the anterior and posterior segments of the small intestine were increased by 1.85 
and 2.28 in SD rats of group C. These results specify that the supplementation of 
prebiotics in infant formula can stimulate enzyme movement in the small intestine 
by improving the relative expression of enzyme gene and Na/Pi-IIb gene and by 
reducing the intestinal injury. The polysaccharides improved to be healthier than 
that of oligosaccharides [124].
4.4.7 Prebiotics and the bioavailability of minerals and trace elements
Prebiotic carbohydrates have positive influence in the absorption of minerals 
and trace elements. There exist a promising evidence about the stimulatory impact 
of prebiotic carbohydrates (non-digestible oligosaccharides and lactulose) on the 
bioavailability of minerals and trace elements. However, most of the studies is on the 
rats because, the studies on the human is limited. It has been hypothesized that pre-
biotics create strong osmotic effect that reduce the pH and stimulate the exchange of 
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protons and increase level of calbindin and butyrate. Colon surface area also enlarged 
that is a good source to increase the minerals and trace elements absorption [125].
4.4.8 Prebiotics in diabetes and cardiovascular diseases
Prediabetes is linked with the long term inflammation that is associated with 
greater risk of developing type 2 diabetes and cardiovascular diseases. Increased con-
centration of lipopolysaccharides is linked with dysbiosis of the natural microbiota 
that is involved in the development of type 2 diabetes and cardiovascular diseases. 
Prebiotics involved in the selective functioning of natural micro biota such as inulin 
decreases the concentration of endotoxin, reduces permeability of the intestines and 
limit the metabolic dysfunction in rodents. The impact of prebiotics on the cardio-
vascular functions in patients at the risk of type 2 diabetes is still unknown. The 
prebiotic supplementation along with inulin could be used as preventive strategy for 
limiting the risk of cardiovascular diseases in the patients at risk of type 2 diabetes. 
This strategy can affect the clinical practices by setting and accepting dietary recom-
mendation of prebiotics by medical and scientific community [126].
4.4.9 Prebiotics and renal profile
It is well documented that prebiotics, probiotics and the symbiotic supplementa-
tion had resulted in the improvement of renal function. Firouzi and Haghighatdoost 
[127] studied renal profile of a meta-analysis of a clinical trial. They pointed out that 
level of glomerular filtration rate was reduced whereas the concentration of creatinine 
was increased in the intervention group in comparison to the placebo group and the 
results were non-significant. The combined effect on the blood urea nitrogen demon-
strated that the level declined as compared to the placebo group. Whereas the levels of 
uric acid increased in intervention group in comparison with the placebo group. The 
supplementation of prebiotics, probiotics and symbiotic should be limited among 
those in which renal function is compromised until well designed and large scale 
randomized controlled trials prove the efficiency and safety of prebiotics, probiotics 
and symbiotic supplementation for having improved effects on the renal function.
4.4.10 Prebiotics in controlling cancer
A study was conducted to check the impact of prebiotics intake consisting of 
xylo-oligosaccharides, fructo-oligosaccharides, resistant dextrin and polydextrose 
on immunity and the structure of gut microbiota in perioperative colorectal cancer 
patients.
A double blind, randomized clinical trial was conducted that consisted of 140 
perioperative colorectal cancer patients involving 50 females and 90 males having 
age between 40 and 75 years. Patients were divided on random basis into two groups 
consisting of intervention group that received 30 g/day of prebiotic supplementa-
tion for the period of 7 days and control group that did not receive supplementa-
tion. The immunological and nutritional indices of both groups were evaluated 
before and after operation and were compared with their baseline levels. Also the 
fecal samples of random 40 patients from the both groups were taken to examine 
the gut microbiota. There was significant reduction in the abundance of intestinal 
microbiata from pre to post operation in the control group. Intake of prebiotics 
is recommended to improve immunological indices in patient having colorectal 
cancer for 7 days before operation. Prebiotics enhanced the concentration of four 
commensal microorganism containing opportunistic pathogens in patients having 
colorectal cancer. Surgical stress decreased the population of intestinal microbiota 
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but increased the population of commensal microbiota and opportunistic microor-
ganisms. For further research Bacteroides is considered as a relevant bacterial species 
on the mechanism of prebiotics [128].
4.4.11 Anxiolytic effect of prebiotics
Long term treatment of prebiotics particularly combination of fructooligosac-
charides and galactooligosaccharides have antidepressant effects and also involved 
in combating the issues related to anxiety. The effect of Galactooligosaccharide 
(GOS) and the combination of fructooligosaccharides and galactooligosaccharides 
is involved in reducing the level of corticosterone level in the body by mainly 
limiting its release. Prebiotics are involved in modifying the expression of specific 
genes related to the concentration of short chain fatty acids in the hypothalamus 
and hippocampus. Administration of Prebiotics resulted in the increased level of 
acetate and propionate and reduction in the concentration of isobutyrate that have 
significant correlation with the positive effects on behavior. Moreover, the admin-
istration fructooligosaccharides and galactooligosaccharides reduced the level of 
corticosterone and proinflammatory cytokines resulted from the chronic stress as 
well as normalizing the anxiety and depression like behavior along with mitigating 
the impact of stress on the microbiota [129].
5. Conclusion
Probiotics and prebiotics are functional foods that have significant biotechno-
logical benefits with wonderful potential for invention. Though probiotics and pre-
biotics are likely to be used in treating many communicable and non-communicable 
disorders but it is very hard to draw conclusions from a number of researches that 
indicating the therapeutic potential of probiotics and prebiotics because scientists 
used different strains and prescriptions for various disorders. Further research 
using reliable regulations will permit more decisive results on the effects of probiot-
ics and prebiotics for treatment of various diseases. Although various products with 
probiotic, prebiotics and symbiotic are usually available in food and supplement 
formats, in near future these products will target to specific disease and will be 
available as drug.
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Gut-Brain Axis: Probiotic, Bacillus 
subtilis, Prevents Aggression via 
the Modification of the Central 
Serotonergic System
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Abstract
Intestinal bacteria release various neuroactive compounds directly or indi-
rectly regulating brain function to modulate host health and behavior through 
the gut-brain axis. Probiotics have been used as dietary supplements to target 
gut microbiota (microbiome) for prevention or therapeutic treatment of various 
diseases including mental disorders. In our study, chickens were used as an animal 
model to assess, if dietary supplementation of probiotic, Bacillus subtilis, reduces 
aggressive behaviors following social challenge. Chickens of an aggressive line 
were housed in single-hen cages. At 24 weeks of age, the hens were paired with 
similar body weight to identify the dominance rank (day 0). The subordinate 
and dominant of each pair were fed a regular layer diet or the diet mixed with 
250 ppm probiotics for 2 weeks, then the second behavior test was performed 
between the same pair (day 14). The display of aggressive behaviors in the regular 
diet-fed chickens was not affected between the levels at day 0 and day 14, while 
the frequency of threat and aggressive pecking were reduced in the probiotic-fed 
chickens compared to the levels at day 0. These results suggest dietary probiotic, 
Bacillus subtilis, could be a suitable strategy for increasing hosts’ mental health.
Keywords: probiotics, Bacillus subtilis, aggression, serotonergic system,  
gut-brain axis
1. Introduction
Human emotional susceptibility in an inter-group is associated with individual 
differences in the functions of the hormonal and/or neurochemical systems in 
response to internal and external stimulations. Aggression, as one of emotional dis-
orders, has been commonly defined as feeling of anger or antipathy of an organism 
during social interaction, leading to hostile of violent behavior or attitude, provok-
ing attack or confront toward another individual [1]. Aggression affects millions of 
people’s health and welfare around the world annually, resulting in significant social 
destruction and economic costs.
Intestinal bacteria, as a virtual endocrine organ, release various neuroac-
tive compounds directly or indirectly regulating brain function, including the 
serotonergic system, to regulate host health and behavior through the gut-brain 
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axis [2–10]. Intestinal bacteria, as well as Bacillus subtilis, used as probiotics are 
involved in tryptophan metabolism [11–14]. Tryptophan metabolites have roles 
in protecting intestinal mucosa from inflammation and regulating gut immune 
homeostasis [15–18]. Tryptophan, a precursor of 5-HT, directly affects brain 5-HT 
synthesis as that tryptophan can pass the brain-blood barrier [19, 20]. The brain 
serotonergic system plays a critical role in regulating behaviors, especially aggres-
sion [21, 22]. Concentrations of 5-HT and its metabolites, as well as the density 
of 5-HT receptors, have been used as major indicators of aggressive behaviors in 
humans and experimental animals [23–26].
Probiotics (also called psychobiotics or bio-friendly agents), defined “as a source 
of live (viable) naturally occurring microorganisms (direct-fed microbials, DFMs)”, 
have been used as dietary supplements to target gut microbiota (microbiome) for 
a novel promising therapeutic approach of various diseases including social stress-
induced mental disorders in humans and various experimental animals [27–36]. 
Different probiotic strains, for example, have been investigated as functional food or 
therapeutic treatment of various diseases, including Bifidobacterium bifidum [37–39]; 
Bifidobacterium bifidum (BGN4) and Bifidobacterium longum (BORI) [40, 41]; 
Bifidobacterium pseudocatenulatum [42]; Lactobacillus helveticus [31, 32]; Lactobacillus 
plantarum [43]; Lactobacillus paracasei (KW3110, [44]); Lactobacillus rhamnosus [45]; 
and Clostridium butyricum [46]. The results collected from these studies indicate that 
the effects of probiotics on physiological homeostasis, immunity, stress resistance, 
and related health status are affected by multiple factors, including the probiotic spe-
cies, its concentration, and duration as well as the host’s age and health status [47, 48].
Bacillus subtilis, as one of the three most common species of probiotic products 
in the United States [49], has been widely used as functional feed supplements, 
such as in a number of dairy and non-dairy fermented foods, for improving human 
health and well-being [50–52]. Similarly, Bacillus subtilis, as growth promoters, has 
been demonstrated to improve chickens’ growth performance [53–55]; regulate 
intestinal microstructure [56] and digestive enzymes [57, 58]; synthesize and 
release antimicrobial and antibiotic compounds [15, 59–63]; increase immunity 
[57, 64] and neurochemical activities including serotonin [8, 65, 66] as well as affect 
animal behavior [67, 68] following various stressors. In addition, Bacillus subtilis 
can overproduce l-tryptophan [11, 69], consequently increase 5-HT in the hypo-
thalamus [70], function as an antidepressant and anti-anxiety agent [71, 72], and 
eliminate nervous tension in mice [73]. In the current study, chickens were used as 
an animal model to assess if dietary supplementation of probiotic, Bacillus subtilis, 
reduces aggressive behaviors following social challenge.
2. Gut microbiota and the gut-brain axis
Gut microbiota is a collective name of ten of trillions of microorganisms living in 
our intestine, including more than 35,000 different species of known bacteria [74]. 
Microbiome refers to the collective genomes of more than 3 million genes of the 
microorganisms in a particular environment. Gut microbiota, like a virtual endo-
crine organ, reacts to various internal and external stimuli [5, 75–78]. Consequently, 
gut microbiota influences and regulates hosts’ health and mood statue including 
aggression by integrating metabolic, immune, endocrine, and neural reactions 
through the bidirectional communication of the gut-brain axis (Figure 1) [7, 33, 
79–83]. Gut microbiota in hosts, for example, regulates brain neurotransmitters 
[84–87] such as serotonin (5-HT) through releasing its precursor, tryptophan, 
an essential amino acid [75, 88–90]. Serotonin is a key neurotransmitter within 
the brain, contributing to the development of the central nervous system (CNS) 
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[91–94] and social behavior [95, 96], affecting mental health [97–100] and pro-
viding therapeutic strategy for treating or preventing stress reaction and related 
neuropsychiatric disorders [94, 97].
2.1 Social stress and the hypothalamic-pituitary-adrenal axis
The social world is filled with different types of interactions, such that social 
challenges (fight-or-flight) and social environmental changes (group instability), 
as stressors, can cause highly potent stress [101–103]. Some management practices 
used in the intensive farm animal production systems, for example, may cause 
stress in animals. Farm animals are often housed in large groups at high densities, 
and during the animals’ lifetimes, they are repeatedly transported to new environ-
ments and mixed with unfamiliar individuals. Based on the social network theory, 
animal group disruption can lead to social stress and related aggression [104] when 
they are unable to cope with these management practices and/or to reset their 
dominance rank (a form of animal social structure hierarchy) [105, 106].
Aggression has been commonly defined as feeling of anger or antipathy during 
social interactions, leading to hostile or destructive behaviors or attitudes, provok-
ing physical or verbal attack or confront toward another individual [1]. Aggressive 
encounters among conspecifics for obtaining or maintaining a socially dominant 
position or rank cause a negative or unstable social environment to activate the 
hypothalamic-pituitary-adrenal (HPA) axis which is known as the key stress 
response system [107–109]. Cortisol (or corticosterone, CORT, in rodents and 
birds), as one of the final hormones released from the adrenal cortex, has multi-
functional functions in both normal and abnormal states, regulating behavioral 
styles, metabolic patterns, and endocrine and immune functions, and ensuring an 
adequate coping strategy and well-being [110–112]. In mammals, hypercortisolism 
in response to novel environment exposures has been evidenced to be of adrenal 
origin [113, 114]. The value of circulating cortisol (or CORT) has been used as a cri-
terion of stress response in humans and various animals [115–117]. Corticotrophin-
releasing factor facilitates aggression [118, 119], and related elevation of CORT (or 
cortisol) also affects neuroendocrine functions through binding to their receptors 
[120, 121], causing neuron loss in the hippocampus [122], dysfunction of the sero-
tonergic system [123], and inhibition of immunity (increased pro-inflammatory 
cytokines as neuroinflammatory response) within stress-sensitive brain regions 
[124]. These changes finally lead to the development of psychological disorders such 
as aggression [109, 125]. Similar to that the HPA hyperactivity generates aggressive 
behavior, exogenous glucocorticoid treatments increase exacerbated aggressiveness 
in both humans and experimental animals [123, 126]. Taken together, emerging 
Figure 1. 
The microbiota-host interaction occurs at the level of the gastrointestinal mucosa via local neural, endocrine, 
and immune activities, influencing brain neurotransmitter expression, physiological homeostasis, and 
immunity (modified from [79]).
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evidence have indicated that the changes of the programming of HPA stress reactiv-
ity [127] cause long-term effects on the host physiological homeostasis and neu-
robehavioral functions [128].
2.2 Microbiota, stress-associated aggression
Aggression within a group is to establish a dominance hierarchy when the animals 
are first brought together in a common environment [129–131]. From an evolution-
ary perspective, aggression is adaptive behaviors that are related to an individual’s 
survival, growth, and reproductive success within a group [132, 133]. However, 
aggression with long-term impact is often destructive and maladaptive in today’s 
society, affecting millions of people’s health and well-being around the world annu-
ally, resulting in significant social destruction and economic costs [134–136].
Intestinal microbiota plays an important role in regulation of social behavior, 
emotional expression, and mental health within the animal kingdom [3, 137, 138]. 
They are essential players in stabilizing homeostasis of the GI tract in response to 
both acute and chronic stress via the microbiota-gut-brain axis [16, 139]. Normally, 
intestinal microbiota provides protection for animals by competing for attachment 
sites and nutrients with pathogens as well as production of antimicrobial peptides 
and neuroactive compounds [140, 141]. The gut microbiota is also a key pathway to 
modulate brain processing the integrated information received from the peripheral 
nerve systems (the vagus nerve, enteric nerve, and autonomic nervous system), 
hormone signaling, the immune system, and microbial metabolites (short-chain 
fatty acids) [5, 137]. Under social challenges, stress and related oxidative damage 
cause anatomical and functional disorders of the GI tract by: (1) disrupting the 
commensal bacterial populations and colonization, thus reducing beneficial bacteria 
and increasing pathogens; (2) increasing pathogen survivability and innovating 
capability; (3) disrupting absorption of nutrients and minerals, including calcium; 
(4) disrupting microbial neuroendocrine functions; (5) disrupting the gut epithelial 
barrier, thereby increasing intestinal permeability causing the gut to leak certain 
bacteria (leaky gut), resulting in metabolic disorder; (6) damaging epithelial cells, 
thus producing free radicals and reducing antioxidant efficacy; and (7) interrupting 
intestinal integrity, thereby leading to intestinal inflammation [142–144]. These 
changes in gut microenvironment affect brain functions, resulting in exacerbated 
HPA axis activity, increased chronic inflammation, and/or disrupted neurotransmit-
ter balance, leading to emotional damage [139, 145] and mental disorders [137, 138]. 
Sudo et al. [146] reported a correlation between the changes of gut microbiota and 
the function of the HPA axis. Germ-free (GF, antibiotic-treated microbiota-deficient 
or raised without any exposure to microorganisms) rats show exaggerated HPA 
responses to psychological stress [75, 147] with significantly higher levels of both 
ACTH and CORT in response to restraint stress compared to control rats [146]. In 
GF mice, gut microbiota also modulates the 5-HT synthesis and release at both the 
brain and peripheral levels directly and indirectly via the microbiota-host interac-
tions [148]. Reduced 5-HT activity (a 5-HT deficiency) has been associated with 
personality traits (interspecific social behavior), such as impulsivity and aggression, 
and deteriorated stress coping capability (increased stress response) in humans and 
various animals [149, 150] including chickens [24, 151–154].
3. Serotonin and aggression
Serotonin, as an ancient chemical, is a key neurotransmitter. It plays a critical 
role in shaping social responses by regulating both basic (proactive) behaviors 
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(such as feeding, drinking, and sexuality) and reactive behaviors (fearfulness, anxi-
ety, and cognition) including aggressive behaviors [155, 156] and mood disorders 
[157, 158]. Abnormalities of blood and brain levels of 5-HT, 5-HIAA (its metabolite, 
5-hydroxyindoleacetic acid), tryptophan, and its receptors have been used as major 
indicators or targets in the diagnoses and treatments of psychiatric and compulsive 
disorders in humans and various experimental animals [62, 63, 159, 160].
In the CNS, 5-HT functions to inhibit aggression, thereby controlling domestic 
behaviors [161–163]. The 5-HT deficiency theory of aggression is driven from the 
negative correlation between the changes of the CNS 5-HT and aggressiveness in 
humans [164, 165], non-human primates [166], rodents [25, 167], and chickens 
[24, 168]. Aggressive animals have low levels of 5-HT in the brain, including in the 
hypothalamus [169–171]. Experimental increase of 5-HT and/or 5-HIAA in the 
brain, such as in the lateral hypothalamus and amygdala, blocks or retracts killing 
behavior in rodents [172, 173]. Hypothalamic injection of a 5-HT1a agonist inhibits 
aggression in male hamsters [174]. Depletion of brain 5-HT in TPH2 mutant mice 
marks aggression and lowers habituation in novel environments [149]. In addition, 
5-HT1BR knockout mice show increased aggression and impulsivity [175, 176]. The 
implication of 5-HT successfully relieves the depression syndromes in humans [177] 
and reduces aggressive behaviors in primates and rodents [178, 179].
In the peripheral system, however, pathophysiological roles of 5-HT in behav-
ioral and motivational regulations are unclear. Reduced, elevated, and unchanged 
blood 5-HT concentrations have all been reported in association with behavioral 
dysfunctions, including aggressiveness [180, 181]. The conflicting data from 
different investigations could be related to the differences in species of animals, 
behavioral evaluations, and/or stressors used as well as duration and frequency of 
stressors presented.
4. Chicken as an animal model for social stress and related aggression
Human emotional susceptibility in an inter-group is associated with indi-
vidual differences in the functions of the hormonal and neurochemical systems 
in response to internal and external stimulations [182, 183]. Various social and 
biological factors are associated with the development and expression of aggressive 
behaviors, including environmental, genetic, cognitive, hormonal, and neurotrans-
mitter circumstances [184]. Aggression and associated mental illness are an emerg-
ing public health problem [29]. Animal models are critical for investigating the 
potential biological processes involved in human aggression and mental disorders.
Although there are dissimilarities between humans and chickens, as indicated, 
the neural circuitry for aggression and social behavior appear to be evolutionarily 
conserved across the vertebrates [185]; chickens have been used as an animal model 
in various clinical and psychopharmacological studies, such as anxiety, depression, 
and aggression [186, 187]. A commercial hen can have more than 300 offspring with 
similar genetic characteristics during her lifetime, and chicks can be hatched with-
out maternal condition effects. Previous studies have reported that birds’ brain pos-
sess a core “social behavioral network” which is humongous to the social behavioral 
network of mammals [188]. There are evidences that the central nuclei involved 
in moodiness in avian, at least in part, are morphofunctional homologous to the 
mammalian nuclei [189], such as the hypothalamus [190], nucleus taeniae (homo-
log to the amygdala of mammals, [191, 192]), and Raphe nucleus [193]. These nuclei 
exert similar cognitive abilities and consciousness [194] with capability of plastic-
ity in response to environmental stimulations [195]. In addition, there are similar 
distributions of neurotransmitter receptors, including serotonergic receptors 
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Serotonin, as an ancient chemical, is a key neurotransmitter. It plays a critical 
role in shaping social responses by regulating both basic (proactive) behaviors 
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(such as feeding, drinking, and sexuality) and reactive behaviors (fearfulness, anxi-
ety, and cognition) including aggressive behaviors [155, 156] and mood disorders 
[157, 158]. Abnormalities of blood and brain levels of 5-HT, 5-HIAA (its metabolite, 
5-hydroxyindoleacetic acid), tryptophan, and its receptors have been used as major 
indicators or targets in the diagnoses and treatments of psychiatric and compulsive 
disorders in humans and various experimental animals [62, 63, 159, 160].
In the CNS, 5-HT functions to inhibit aggression, thereby controlling domestic 
behaviors [161–163]. The 5-HT deficiency theory of aggression is driven from the 
negative correlation between the changes of the CNS 5-HT and aggressiveness in 
humans [164, 165], non-human primates [166], rodents [25, 167], and chickens 
[24, 168]. Aggressive animals have low levels of 5-HT in the brain, including in the 
hypothalamus [169–171]. Experimental increase of 5-HT and/or 5-HIAA in the 
brain, such as in the lateral hypothalamus and amygdala, blocks or retracts killing 
behavior in rodents [172, 173]. Hypothalamic injection of a 5-HT1a agonist inhibits 
aggression in male hamsters [174]. Depletion of brain 5-HT in TPH2 mutant mice 
marks aggression and lowers habituation in novel environments [149]. In addition, 
5-HT1BR knockout mice show increased aggression and impulsivity [175, 176]. The 
implication of 5-HT successfully relieves the depression syndromes in humans [177] 
and reduces aggressive behaviors in primates and rodents [178, 179].
In the peripheral system, however, pathophysiological roles of 5-HT in behav-
ioral and motivational regulations are unclear. Reduced, elevated, and unchanged 
blood 5-HT concentrations have all been reported in association with behavioral 
dysfunctions, including aggressiveness [180, 181]. The conflicting data from 
different investigations could be related to the differences in species of animals, 
behavioral evaluations, and/or stressors used as well as duration and frequency of 
stressors presented.
4. Chicken as an animal model for social stress and related aggression
Human emotional susceptibility in an inter-group is associated with indi-
vidual differences in the functions of the hormonal and neurochemical systems 
in response to internal and external stimulations [182, 183]. Various social and 
biological factors are associated with the development and expression of aggressive 
behaviors, including environmental, genetic, cognitive, hormonal, and neurotrans-
mitter circumstances [184]. Aggression and associated mental illness are an emerg-
ing public health problem [29]. Animal models are critical for investigating the 
potential biological processes involved in human aggression and mental disorders.
Although there are dissimilarities between humans and chickens, as indicated, 
the neural circuitry for aggression and social behavior appear to be evolutionarily 
conserved across the vertebrates [185]; chickens have been used as an animal model 
in various clinical and psychopharmacological studies, such as anxiety, depression, 
and aggression [186, 187]. A commercial hen can have more than 300 offspring with 
similar genetic characteristics during her lifetime, and chicks can be hatched with-
out maternal condition effects. Previous studies have reported that birds’ brain pos-
sess a core “social behavioral network” which is humongous to the social behavioral 
network of mammals [188]. There are evidences that the central nuclei involved 
in moodiness in avian, at least in part, are morphofunctional homologous to the 
mammalian nuclei [189], such as the hypothalamus [190], nucleus taeniae (homo-
log to the amygdala of mammals, [191, 192]), and Raphe nucleus [193]. These nuclei 
exert similar cognitive abilities and consciousness [194] with capability of plastic-
ity in response to environmental stimulations [195]. In addition, there are similar 
distributions of neurotransmitter receptors, including serotonergic receptors 
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between birds and mammals  [196, 197]. Particularly, it has been evidenced that the 
development and function of avian HPA axis in response to stimuli are analogous 
to those of mammals [198, 199] and there are similar distributions of cortisol-like 
molecules in the same organs from both birds and mammals [200]. Birds’ CORT 
biosynthesis and metabolism can be stimulated in the same way as that of mammals 
[201–203]. During breeding, functional integrations among behavior, physiology, 
morphology, and environment in chickens may create suites of various traits that 
are simultaneously acted upon each selection program [204]. For example, selection 
based on individual production capability (phenotypic characteristics) increases 
animals’ competition and aggression [205, 206] such as potentially injurious feather 
pecking and cannibalism. For instance, through more than 20 years of selection, 
egg production had been increased significantly in a former commercial Dekalb XL 
strain, whereas mortality due to aggression and cannibalism in non-beak trimmed 
hens had also increased about 10-fold [132, 152].
Results from previous studies conducted in our laboratory have found that 
chicken strain dif fers in social reactions through a diversely genetic selection 
program. The DXL hens have distinct stress levels in attempting to adapt to their 
social environments [207, 208] and exhibit different levels of aggressiveness [168]. 
In addition, neurotransmitters, 5-HT and dopamine (DA), and the hypothalamic-
pituitary-adrenal (HPA) axis are regulated differently between chicken strains 
[168, 207]. There results suggest that injurious behaviors and related social sensi-
tivity of chickens, similar to that in mammals, are regulated via the serotonergic 
system and the HPA axis [123, 209], and mechanisms underlying aggression in 
laying hens may be analogous to those of humans and rodents [210]. Similarly in 
humans and rodents, stress-induced destruction of intestinal bacteria disturbs 
the bilateral connection of the microbiota-gut-brain axis in chickens, affecting 
physiological homeostasis and behavioral exhibition [211]. In one of our studies, 
the role of probiotic, Bacillus subtilis, on aggression in DXL line was examined. 
In the study, one-day-old female chicks were reared in single-bird cages up to 
24 weeks. At 24 weeks of age, the hens with similar body weight were paired for the 
first aggression test (pre-treatment, day 0) in a novel floor pen [212]. Behaviors 
were video-taped for 2 h immediately after releasing the two hens simultaneously 
into the floor pen to determine the dominant individual per pair. Following the 
behavioral test, the subordinate hens were continuously fed the regular diet, while 
the dominant hens were fed the diet mixed with 250 ppm probiotic (1.0 × 106 cfu/g 
of feed) for 2 weeks. The probiotic contains three proprietary strains of B. subtilis. 
After the treatment (day 14), the second aggression test was conducted within 
the same pair of hens. The video recording was analyzed for frequency of feather 
pecking, threat, aggressive pecking, and threat kick by the routine lab procedures 




One bird pecking at feathers of another bird, can be gentle (nibbling or gentle pecking 
in which feathers are not removed or pulled) or severe (vigorous pecking to feathers in 
which feathers are often pulled, broken, or removed)
Threat One bird standing with its neck erect and hackle feathers raised in front of another bird
Aggressive 
pecking
Forceful downward pecks directed at the head or neck of other birds
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5. Probiotic, Bacillus subtilis, and aggression
As social animals, chickens show fear, depression, and/or anxiety in novel envi-
ronments and show aggression toward ones for establishing social dominance rank 
in unfamiliar social groups [214, 215], which is similar to rodents used in human 
psychopharmacological studies [216, 217]. The paired social ranking-associated 
behavioral test used in this study has been routinely performed in chicken behav-
ioral analysis [154, 213, 218]. The rationale and cellular mechanisms of the test is 
similar to the resident-intruder test which is a standardized method used in rodents 
for detecting social stress-induced aggression and violence [219, 220].
5.1 Probiotics and Bacillus spp.
A healthy intestinal microbiota community is important for maintaining physi-
ological and behavioral homeostasis as that the gut microbiota regulates appetite, 
local and systemic immunity, stress responses of the HPA and sympathetic- 
medullary-adrenal (SMA) axes, and circadian rhythms [5, 221]. The new strate-
gies of psychotherapy aimed at restoring the normal gut microbiota and intestinal 
homeostasis have been developed for the prevention and/or reduction of stress-
induced abnormal behaviors and mental disorders.
Probiotics are commensal bacteria (“direct-fed microbials”, DFM) that offer 
potential health beneficial bio-physiological effects to the host’s stress response 
(acute, chronic, or both). Probiotics aid animals in adapting to their environments 
and protect against pathogens by: (1) altering the microbiota profile with beneficial 
bacteria to prevent the growth of pathogens and to compete with enteric pathogens 
for the limited availability of nutrient and attachment sites; (2) producing bacte-
riocins (such as bacteriostatic and bactericidal substances) and short-chain fatty 
acids against pathogens to regulate the activity of intestinal digestive enzymes and 
energy homeostasis and to increase mineral solubility; (3) reducing oxidative stress, 
inflammation, and acinar cell injury; (4) modulating host immune and inflam-
matory responses and restoring the intestinal barrier integrity which prevents 
pathogens from crossing the mucosal epithelium; (5) stimulating the endocrine 
system and attenuating stress-induced disorders of the HPA and/or SMA axes via 
the gut-brain axis; and (6) inducing epithelial heat shock proteins to protect cells 
from oxidative damage; and (7) synthesis and secretion of neurotransmitter such as 
5-HT and tryptophan [16, 17, 222–226]. In both human and rodent studies, probiot-
ics reduce cognitive dysfunction, decrease the stress response and related oxidative 
damage by lowing plasma CORT and ACTH levels, restore hippocampal 5-HT 
levels, and normalize immunity with low plasma levels of TNF-α (tumor necrosis 
factor-α), a proinflammatory cytokine, but high levels of IL-10 (Interleukin-10), an 
anti-inflammatory cytokine [67, 227–230]. It has been stated in nonhuman primate 
models that the composition of the gut microbiota has potential effects on hosts’ 
aggressive behaviors and anxiety symptoms [127], which is similar to the findings 
reported in humans [137, 231–233]. In rodent studies, GF animals with exaggerated 
HPA responses to social stress can be normalized by certain probiotics [147]. In 
addition, probiotics have successfully attenuated anxiety and depressive behaviors 
in rat offspring separated from their mother [234–236] and the obsessive- 
compulsive-like behaviors in house mice [28, 237]. These results support the psy-
chobiotics theory [238] and provide a new insight into the possible use of probiotics 
to improve a host’s cognitive function in humans [9, 40, 41, 239–243].
A proposed strategy for improving human health is dietary supplement with 
probiotic microorganisms including Bacillus species [52, 244]. Bacillus subtilis 
is spore-forming bacteria. They have heat stability and low pH-resistance  (the 
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gastric barrier), and tolerate multiple environmental stressors [245, 246]. Several 
Bacillus spp. such as B. coagulans and B. subtilis have been used as probiotics in 
both humans [247–249] and animals [246] including poultry [65, 67, 250, 251]. 
Several mechanisms of action of Bacillus spp. have been proposed: the improve-
ment of hosts’ growth, survival, and health status via their anti-inflammatory 
functions through immunomodulation and cytoprotection [252, 253]. And, they 
have been used as antibiotic growth promoters alternatives with health-promoting 
benefits by naturally synthesizing proteins, enzymes, antimicrobial peptides, vita-
mins, gut flora modulation to promote beneficial microbiota along the GI tract and 
to correct and repair immunological and gut morphological alterations [244, 246, 
250, 254, 255]. In addition, numerous studies have shown that probiotic-induced 
changes in the composition of gut microbiota lead to alterations of neuroendocrine 
functions. For example, in response stimulations, B. subtilis alleviate oxidative 
stress, provoke a specific biological response, and improve mood status of hosts via 
the gut-brain axis [52, 147, 256].
5.2 Bacillus subtilis-based probiotic and social challenge-induced aggression
Aggression, in nature, is associated with competition (natural selection) for 
survival and reproduction [22, 257, 258] (please also see above for the detailed 
description). However, in artificial production environments, such as in the 
poultry industry, aggression causes increased social stress and feather and body 
damage, in some instances these injuries leading ultimately to cannibalism. 
Cannibalism is a major concern related to non-beak trimmed bird deaths in cur-
rent housing environments [259, 260]. Beak trimming (BT) is a routine procedure 
practiced in the US egg industry for reducing social stress by preventing and/or 
inhibiting feather pecking and cannibalism. However, BT is criticized for causing 
tissue damage and pain (acute, chronic, or both), negatively affecting the welfare 
of billions of chickens annually [261, 262]. Considerable concern from the public 
has led to a growing movement against procedures causing pain and suffering 
in farm animals. In response to growing pressures, housing environments of 
laying hens have been modified and/or various dietary supplementations have 
been provided in attempts to prevent social stress and stress-associated injurious 
behaviors. For instance, modifications include reducing light intensity, changing 
the nutritive value or taste of diets [263–265], providing straw or grain [266, 267] 
or pelleted diets [263], housing hens in floor-pens [268], and developing enriched 
cages [269, 270]. However, these methods have had limited success and provide no 
guarantee of preventing these injurious behaviors. Therefore, an obvious solution 
is to develop a welfare-friendly alternative to BT that minimizes social stress, 
thereby preventing feather pecking and cannibalism. The hypothesis was tested 
in this study: probiotics could be an alternative to beak trimming in chickens for 
reducing feather pecking and aggression via regulating the gut-brain axis.
Based on the 5-HT deficiency theory of aggression, social challenge-induced 
changes in 5-HT concentration were examined in this study. In the current study, 
the data showed that prior to the treatment (day 0), plasma 5-HT levels were 
higher (26% increase) in the dominant hens than that of subordinate hens but 
were not statistically significant (P = 0.24. Dominant5-HT = 17.46 ng/ml,  
Subordinate5-HT = 13.87 ng/ml). This finding is in agreement with the results 
reported previously [152, 168]. In those studies, higher plasma levels of 5-HT 
were detected in hens from mean bad bird (MBB) strain, a high aggressive strain 
selected for both low productivity and low longevity resulting from injurious 
pecking and cannibalism, compared to hens from kind gentle bird (KGB), a 
low aggressive strain selected for both high productivity and high longevity. In 
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addition, Bolhuis et al. [271] proposed that blood 5-HT activity is correlated with 
the development of severe feather pecking in laying hens. A similar correlation 
between blood 5-HT levels and aggressiveness has also been detected in humans 
and various other animals, that is, a lower blood 5-HT level was associated with less 
aggressive individuals in humans [180, 272] and canine [273], while an elevated 
blood 5-HT level was determined in patients with aggressive behaviors [274] and in 
aggressive teleost fish [275].
Post-treatment (day 14), plasma 5-HT levels were reduced toward the levels of 
controls (subordinates) in the probiotic fed dominant hens (P = 0.02) compared 
to their related levels prior to treatment (day 0) (Figure 2). There were no treat-
ment effects on plasma 5-HT concentrations in subordinate hens fed a regular diet 
(P = 0.88). Although the reasons of the reduction of plasma 5-HT concentrations in 
probiotic fed hens are still unclear but could be similar to those proposed in probi-
otic-treated patients with intestinal inflammatory disorders such as irritable bowel 
syndrome (IBS) and IBS experimental animals. Probiotics reduce IBS-associated 
abdominal pain and abnormal bowel habits [276, 277] through regulation of both 
the central and peripheral serotonergic systems via the microbiota-gut-brain axis 
[278, 279] and gut epithelial enterochromaffin cells [19]. In the peripheral system, 
probiotics reduce or inhibit IBS-associated serotonergic system abnormalities, that 
is, great hypersensitivity and spontaneous release of 5-HT [280, 281]. Serotonin 
reuptake transporter (SERT or 5-HTT) has functions in inactivating 5-HT. Down-
regulation of SERT receptors has been found in the intestinal mucosa of IBS patient 
whose symptoms are similar to those found in the SERT knockout mice [282]. 
Serotonin 5-HT3 receptor antagonist also has shown efficacy in treating IBS patients 
[278, 283]. In addition, Wikoff et al. [284] reported that conventional mice had 
lower concentrations of 5-HT compared to GF mice. GF mice also had an exag-
gerated stress response [146] with anxiety-like behaviors [285]. These abnormal 
behaviors in GF mice can be inhibited or reduced by feeding probiotics [286] or 
transplanting fecal samples of conventional mice [287]. The current and previous 
Figure 2. 
Plasma serotonin (5-HT) levels at day 0 (pre-treatment) and day 14 (post-treatment) in probiotic fed 
dominant hens and regular diet fed subordinate hens. Compared to subordinate hens, plasma 5-HT 
concentrations were higher in dominant hens at day 0 but without statistical difference (P = 0.24); the 
difference disappeared at day 14. Compared to the levels at day 0, blood concentrations of 5-HT were 
reduced in probiotic fed dominant hens at day 14 (P = 0.02) but were not in regular diet fed subordinate hens 
(P > 0.05). a,b between the concentrations at day 0 and day 14, least square means lacking common superscripts 
differ (P < 0.05).
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Figure 2. 
Plasma serotonin (5-HT) levels at day 0 (pre-treatment) and day 14 (post-treatment) in probiotic fed 
dominant hens and regular diet fed subordinate hens. Compared to subordinate hens, plasma 5-HT 
concentrations were higher in dominant hens at day 0 but without statistical difference (P = 0.24); the 
difference disappeared at day 14. Compared to the levels at day 0, blood concentrations of 5-HT were 
reduced in probiotic fed dominant hens at day 14 (P = 0.02) but were not in regular diet fed subordinate hens 
(P > 0.05). a,b between the concentrations at day 0 and day 14, least square means lacking common superscripts 
differ (P < 0.05).
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results indicate that normal health gut microbiota plays an important role in regu-
lating social stress and stress-associated behaviors.
Whether the changes of blood 5-HT levels in probiotic fed dominant hens 
represent a similar change of 5-HT concentrations in the brain is unclear, as 5-HT 
cannot pass the brain-blood barrier and is regulated differently between brain 
neurons and peripheral tissues [288]. The plasma 5-HT is synthesized mainly by the 
EC cells of the gut and stored in the platelets [289]. However, it has been proposed 
that platelet 5-HT uptake is a peripheral marker of brain 5-HT [273]. Dietary 
probiotic, Lactobacillus plantarum strain PS128, increases the levels of 5-HT as well 
as dopamine in the striatum, which is correlated with the improvement of anxiety-
like behaviors in GF mice [290]. Similar results have been received from our current 
studies. In one study, chickens (broilers) were fed Bacillus subtilis from day one. At 
day 43, Bacillus subtilis fed chickens had higher levels of 5-HT in the raphe nuclei 
and lower levels of norepinephrine and DA in the hypothalamus than controls 
[291]. Probiotic fed chickens also had improved bone traits (bone mineral density, 
bone mineral content, and robusticity index). Under heat stress (32°C), Bacillus 
subtilis fed chickens had lower heat stress-related behaviors and inflammatory 
response and reduced IL-6 levels in the hypothalamus compared to controls [67]. 
Further studies, however, are needed to examine if there are correlations between 
the regulations of peripheral 5-HT and CNS 5-HT in probiotic fed hens.
The gut commensal microflora may have an indirect effect on 5-HT synthesis 
by regulating tryptophan metabolism. The degradation of tryptophan, a precursor 
of 5-HT, is mainly through the kynurenine pathway which regulates over 95% of 
tryptophan in the peripheral system and is functionally mediated by gut microbiota 
and probiotics [147, 292]. In the present study, the tryptophan level was not signifi-
cantly affected by dietary probiotic (P = 0.35), but the initial levels of tryptophan 
in dominant hens were approximately 28% higher than the subdominant hens 
(P = 0.21) (Figure 3). The pattern of changes in blood concentrations of trypto-
phan in probiotic fed dominant hens was correlated with the changes of peripheral 
concentrations of 5-HT, indicating that probiotic may directly or indirectly regulate 
5-HT synthesis in the peripheral system.
In this study, behavioral changes in dominant hens were correlated with the 
changes of blood 5-HT concentrations following fed probiotic. In the probiotic fed 
dominant hens, the levels of threat kick were reduced (Figure 4a, P = 0.04), and 
the frequency of aggressive pecking tended to be lower (Figure 4b, P = 0.053). 
The levels of feather pecking in dominant hens were reduced compared to their 
initial levels at day 0 but without statistic significant (Figure 4c, 58%, P > 0.05). 
There was no change in injurious behaviors in the regular diet fed subordinate hens 
between day 0 and day 14 (Figure 4a–d). The same or similar cellular mechanisms 
proposed in humans and rodents may be applied to the changes in the probiotic fed 
dominant hens. In humans and rodents, probiotics directly manipulate commensal 
bacteria releasing neuroactive factors, such as 5-HT and norepinephrine [8], and 
indirectly affect the neurotransmitter metabolisms, such as tryptophan as well as 
cytokines, through the microbiota-gut-brain axis [5, 40, 41, 279, 293–297]. In addi-
tion, the effects of probiotics, including B. sublitis, on behavioral exhibitions have 
been conducted on GF mice. Bercik et al. [287] reported that anxiety behaviors can 
be induced in less anxious phenotypic mice by colonization of the gut bacteria from 
anxiety-like phenotypic mice (FMT, fecal microbiota transplant). Probiotics also 
have therapeutic effects on neurodevelopmental disorders [28, 95, 298–301], for 
example, reduced anxiety-like behaviors by providing L. helveticus, Mycobacterium 
vaccae, and/or Bifidobacterium strains [231, 287, 302, 303], and alleviated autism-
related stereotypic behaviors by treating with Bacteroides fragilis [304] and behav-
ioral dysfunction with Lactobacillus reuteri [301, 305].
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In the current study, body weight gain and hen-day egg production were not 
affected in the probiotic fed hens compared with the regular diet fed control hens 
(Control = 2.83%, Probiotics = 2.2%, P = 0.76; Control = 73.6%, Probiotics = 87.5%, 
Figure 3. 
Plasma tryptophan levels at day 0 (pre-treatment) and day 14 (post-treatment) in probiotic fed hens and 
regular diet fed hens. Prior to treatment, dominant hens had higher tryptophan concentrations compared to 
subordinates but the difference did not reach statistical difference (P = 0.21). There were no treatment effects on 
tryptophan concentrations in both probiotic fed hens and regular diet fed hens (P > 0.05, respectively).
Figure 4. 
Frequency of aggressive behaviors at day 0 (pre-treatment) and day 14 (post-treatment) in probiotic fed hens 
and regular diet fed hens followed the paired social test. The exhibitions of aggressive behaviors in the regular 
diet fed subordinates were not affected by treatment (P > 0.05, respectively), while the frequency of threat 
kick (P = 0.04) was reduced, aggressive pecking (P = 0.053) was tend to be lower, and feather packing was 
declined (60%, P = 0.33) in probiotic fed dominates post-treatment. Notes: the treatment effects on the measured 
behaviors were reversed between dominants and subordinates during the 2nd social rank test. a,b between the 
frequency at day 0 and day 14, least square means lacking common superscripts differ (P < 0.05); and † a trend 
difference (0.05 ≤ P < 0.10).
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P = 0.18, respectively). Previous studies have reported the beneficial effects of 
dietary supplementation of probiotics on daily weight gain, finished body weight, 
and feed conversion rate in broiler chickens [306, 307], turkeys [308], and swine 
[309]. Several studies also reported that probiotic diets improved egg production 
in hens [310]. The underlying mechanisms of these effects may be related to the 
beneficial bacterial growth in the gastrointestinal tract to facilitate the fermentation 
process which improves the digestion and utilization of nutrients in animals [311]. 
The beneficial effects on growth performance, however, are affected by the bacte-
rial strains, preparation process, dosage, animal’s age, and genetic type [312, 313]. 
In the current study, the probiotic was provided for 2 weeks only, which may not be 
sufficient to functionally improve both growth and production performance.
6. Conclusions
Our data suggest that dietary inclusion of probiotics has positive effects on 
reducing agonistic behaviors in laying hens through modification of the serotoner-
gic system without negative effects on growth and production performance. The 
data indicate that dietary probiotic supplementation could be a useful management 
tool for preventing aggressive behaviors in laying hens. In addition, the current 
chicken strain could be a useful model to investigate mechanisms underlying the 
potentially probiotic therapy for preventing and reducing emotional susceptibility 
associated with psychiatric disorders such as depression and anxiety in humans.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Oral Health by Using Probiotic 
Products
Razzagh Mahmoudi, Sara Moosazad and Katayoon Aghaei
Abstract
One of the most prevalent and important health problems in the world is 
periodontal and plaque-related diseases that antibiotic drugs are used with their 
side effects as their treatment. With increasing resistance to antibiotics and a 
desire from the general public for “natural” therapies, there is a need to minimize 
antibiotic use and develop new treatments for oral diseases without antimicrobial 
agents. Probiotics are viable microorganisms which provide a health benefit to 
the host when administered in adequate amounts; studies show that probiotics 
have the potential to modify the oral microbiota and decrease the colony-forming 
unit (CFU) counts of the oral pathogens being investigated to prevent or treat 
oral disease, such as dental caries and the periodontal diseases. In addition, the 
identification of specific strains with probiotic activity is required for any oral 
infectious disease, in order to determine the exact dose, the time of treatment, and 
the ideal vehicle.
Keywords: probiotics, periodontal diseases, dental caries, oral health
1. Introduction
As we know tooth decay and oral health is one of the most common worries 
in the world [1], and with widespread public concern about the use of industrial 
drugs to reduce dental caries, natural base treatments are highly welcomed, but the 
question is: Can probiotics be used as a therapeutic agent? A few years before 1908, 
the theory is drawn up according to this theory; the Bulgarian people have a longer 
life; the reason of longer life was Bulgarian people used more fermented products. 
These products have increased the health of their digestive system [2]. This theory 
won the Nobel Prize in Physiology and Medicine (1908) [3]. Since then, many 
publications that have referred to this theory said using probiotic products can 
be factor in improving the health of the digestive system, reproductive organs, 
and oral hygiene [4, 5]. Oral holes are environments with homeostasis conditions, 
which affect the nutritional conditions and individual health conditions and 
conditions of the environment [3, 4, 6]. Probiotics, as nonpathogenic microorgan-
isms, can have beneficial health benefits at low levels in food. They have the ability 
to change this homeostasis environment [3, 7]. Probiotic bacteria consist of two 
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Abstract
One of the most prevalent and important health problems in the world is 
periodontal and plaque-related diseases that antibiotic drugs are used with their 
side effects as their treatment. With increasing resistance to antibiotics and a 
desire from the general public for “natural” therapies, there is a need to minimize 
antibiotic use and develop new treatments for oral diseases without antimicrobial 
agents. Probiotics are viable microorganisms which provide a health benefit to 
the host when administered in adequate amounts; studies show that probiotics 
have the potential to modify the oral microbiota and decrease the colony-forming 
unit (CFU) counts of the oral pathogens being investigated to prevent or treat 
oral disease, such as dental caries and the periodontal diseases. In addition, the 
identification of specific strains with probiotic activity is required for any oral 
infectious disease, in order to determine the exact dose, the time of treatment, and 
the ideal vehicle.
Keywords: probiotics, periodontal diseases, dental caries, oral health
1. Introduction
As we know tooth decay and oral health is one of the most common worries 
in the world [1], and with widespread public concern about the use of industrial 
drugs to reduce dental caries, natural base treatments are highly welcomed, but the 
question is: Can probiotics be used as a therapeutic agent? A few years before 1908, 
the theory is drawn up according to this theory; the Bulgarian people have a longer 
life; the reason of longer life was Bulgarian people used more fermented products. 
These products have increased the health of their digestive system [2]. This theory 
won the Nobel Prize in Physiology and Medicine (1908) [3]. Since then, many 
publications that have referred to this theory said using probiotic products can 
be factor in improving the health of the digestive system, reproductive organs, 
and oral hygiene [4, 5]. Oral holes are environments with homeostasis conditions, 
which affect the nutritional conditions and individual health conditions and 
conditions of the environment [3, 4, 6]. Probiotics, as nonpathogenic microorgan-
isms, can have beneficial health benefits at low levels in food. They have the ability 
to change this homeostasis environment [3, 7]. Probiotic bacteria consist of two 
main groups of Lactobacillus and Bifidobacterium. The Lactobacillus, as a member 
of oral microbial flora, can play an important role in the microcosm balance of the 
oral cavity. Less information is available about the useful role of Bifidobacterium in 
oral cavity health [8, 9].
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2. Oral health
The mouth has a varied and heterogeneous microbial community. Oral health 
can be a state of being free from chronic mouth and tooth pain, such as oral and 
throat cancer, tooth loss, periodontal disease, and the other diseases that affect 
this tissue. The etiology of periodontal diseases and caries shows the prevalence of 
these both having microbial components. Host microbiota has important role in the 
individual’s health. The theory from Nobel laureate Ilya Metchnikoff says “we fight 
microbe with microbe” and has attracted numerous followers [10].
3. Probiotics background
As we know, the presence of microorganisms in the body always had been a 
concern of a large group of scientists. Because the health of the oral and intestinal 
organs is depends on the balance of these microorganisms and their functioning 
[10]. For many years, scientists and doctors have been using antibiotics to improve 
the function of the oral cavity, lymph system, and intestinal organs and control the 
demographic of these microorganisms. However, the widespread use of antibiotics 
not only caused a lot of problems in the human body but also led to microorganisms 
exhibiting resistance and even in some cases caused new species in microorganisms. 
All these problems forced scientists and researchers to find new methods for control-
ling microorganisms in the body organs.
4. Probiotic bacteria
As it is mentioned in the introduction, probiotic bacteria consist of two main 
groups of Lactobacillus and Bifidobacterium. The best growth environments for 
these two groups are anaerobic or minimal oxygen conditions, for example, in 
saliva, vagina, vegetable juices, and dairy products. Probiotic bacteria were used in 
a variety of ways over time. For example, and prevent food corruption, Today, these 
bacteria are also used in industrial food products such as milk, wine and vegetables 
[11]. The name probiotic comes from the Greek word probosis, which means for life. 
This word was first used in 1965 by Lily and Stool to describe the secreted mate-
rial by microorganisms to stimulate the growth of other microorganisms. In 1974, 
Parker introduced the word to describe microorganisms controlling the intestinal 
microbial population [12–14]. Today, probiotic bacteria refer to viable microorgan-
isms that control the microbial population of the gut. They have lots of positive 
effects on the health of the host such as reduced constipation, decreased blood 
cholesterol, and improved lactose tolerance and calcium intake [14].
5. Probiotic foods are functional foods
Diets play an important role in health. These diets can play a leading role in 
reducing disease. Today, with increasing awareness of people about the beneficial 
effects of probiotic bacteria, consumption of functional foods is increasing. But 
what are these foods? Functional foods are such food that promotes health [14]. A 
wide range of foods are included, but the most important ones are oligosaccharides 
and probiotic foods [15].
What are the main criteria for selecting probiotic food as functional? Functional 
food must have three items:
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1. They have a different effect from a nutritional point.
2. They reduce the risk of pathological illnesses.
3. Consuming them benefits the community and the consumer [15].
Probiotic foods not only have the main characteristics that are mentioned but 
also have more benefits. These features include:
A. Useful effects on the host
B. High shelf life in the product
C. Ability to survive the intestines
D. Ability to produce antimicrobial agents
E. Stabilization of intestinal flora
F. Nonpathogenicity and non-toxicity [16]
6.  Which foods have the best tissue for the transfer of probiotic bacteria 
to the human digestive system?
New food products are converted into probiotic foods by adding probiotic 
bacteria. These foods include a variety of different types such as cheese, ice cream, 
milk-based dessert, baby milk, and mayonnaise. In making these foods, the main 
thing is the texture of these foods. It can be said that among all foods, dairy prod-
ucts are known as the best option for the transmission of probiotic bacteria [17–20].
7. What are the main mechanism probiotics in the body?
Probiotics can function through several mechanisms. Probiotic bacteria 
through colonization in the intestinal environment, connect to each other, using 
the food in the body before it is taken by pathogenic microorganisms so by creat-
ing competition, it eliminates pathogens. Also, probiotics, unlike many harmful 
bacteria, are capable of producing acid to survive in the regulation of the local 
and systemic immune system [21].
8. Probiotics and dental caries
Dental caries is one of the most common oral diseases, even though it is prevent-
able. There are different reasons for dental caries such as such as maternal char-
acteristics, environment, child’s individual factors and epigenetics, and sugar and 
sugar-rich diet [10]. A usual feature for caries-promoting bacteria is that they are 
acidogenic and aciduric. One of the most caries-promoting bacteria is Streptococcus 
mutans. For this reason lactobacilli and bifidobacteria are excellent acid producers, 
since we can use probiotics several times a day and they are safe for infants [22].
9. Probiotics and periodontal disease
Periodontal diseases include gingivitis and periodontitis. They are manifested 
by bleeding on probing, swelling, color alterations, pain, and tooth mobility in 
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advanced stages. Scaling and root planning and deep pocket debridement are usual 
treatments [10]. Periodontal pathogens could be regulated by means of antagonis-
tic interactions. According to the results of studies probiotics have been shown to 
reduce the number of the most frequently isolated pathogens such as Bacteroides 
sp., Actinomyces sp., Staphylococcus intermedius, and Candida albicans at optimal 
concentrations of 108 cfu/ml [23].
10. Probiotics and oral candida infections
Another role of a probiotic is to restrain the chronic candida infections of the 
soft tissues in the mouth. Those that are isolated from oral cavity include C. albi-
cans, C. glabrata, C. krusei, C. parapsilosis, and C. tropicalis. Many in vitro studies 
have shown that the strains of lactobacilli have inhibitory activity against oral 
candida, but the true value of probiotics in controlling oral candida is still an open 
question [10].
11. Probiotics and halitosis
One of the most common problems that people in the world suffer from is 
halitosis. This phrase is used in 1921 to describe the unpleasant odor of the mouth 
[23]. This complication has many causes such as bacterial coating of the tongue, 
systemic disorders, and different types of food [24]. At all levels, all physical 
and chemical treatments alone have not been able to completely control this 
pathology. All physical and chemical treatments alone have not been able to fully 
control this problem. Today, scientists believe that the use of probiotics as sup-
portive therapies will play a role in controlling this problem. But how can these 
bacteria help?
1. Probiotics can act as antibiotics and inhibit gastrointestinal diseases, which can 
reduce the odor associated with these diseases.
2. Probiotics can reduce bacteria in terms of immunity.
These two methods are the main methods for reducing odor in the mouth by 
probiotics [25].
12. Mechanism of probiotics in the oral cavity
The ability to adhere to and colonize surfaces in the oral cavity is an essential 
requirement for an oral probiotic [9]. There are four main mechanisms for the 
effect of probiotic bacteria in the mouth. Probiotics compete with pathogens to 
stick to the mucosa and tooth and prevent the sticking of pathogenic bacteria 
[26]. Probiotic produce peroxide and bacteriocin as antibacterial agents against 
oral pathogens, so they remove from oral area [27]. The presence of probiotics 
can change the oral conditions such as reducing pH that can prevent the growth 
of bacteria producing tooth decay or change the protein structure of salivary 
gland [28]. Probiotics can have beneficial effects on dental health by stimu-
lating non-specific immunity and regulating cellular and humoral immune 
responses [29].
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13. Probiotic strain in oral cavity
According to the researches and their results, Lactobacilli and Bifidobacterium 
could play an important role in the microecological balance in the oral cavity. B. 
bifidum, B. longum, and B. infantis are the probiotic species of Bifidobacterium. 
Bifidobacterium is seen in deep caries in the oral cavity and plays an important role 
in the development of caries, but it has been shown that its probiotic species can 
reduce caries in people who do not have active caries. Acidophilus are the probiotic 
species of Lactobacillus. According to the researches, Lactobacillus is more associ-
ated with decayed dentin. It is at the point of development of the decayed lesion and 
is at the onset of the process that caries do not have a role. Consumption of products 
of probiotics does not predict the cause of decay growth. Firstly, the Lactobacillus 
rarely causes cavity formation. Secondly, all Lactobacillus species do not induce 
caries, and thirdly when carriers of dairy Lactobacillus are present, they can have a 
neutralizing effect on acid production by bacteria [30].
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Abstract
On example of Lactobacillus and Bifidobacterium strains, approaches in cre-
ation of human multistrain probiotic metabolite mixtures for different goals were 
proposed. Human probiotic lectin systems (LS) (mucosal, others) reveal func-
tions needed for organism. Advanced features of such systems include capability 
to recognize synthetic polymeric polyvalent glycoconjugates (GC)—imitators of 
natural ones (modified polysaccharides, glycoantigens of medical significance). 
Probiotic lectin systems function as imitators of multipro-/sym-/synbiotics in their 
resulting actions. They serve as carriers of the biotope glycoconjugate décor includ-
ing glycoprebiotics, glycometabiotics, glycodrugs, and agents supporting décor 
organization and resistance. Probiotic lectin systems represent new perspective 
system agents to improve the health of mucosal microbiocenoses (MB) organized 
as communicative bodies to be corrected according to the principle “there is body—
there are diseases.” They act as metabolomebiotics according to the principle “the 
network in the network.” They deepen biotope resistance allowing quicker return to 
balance. They support prophylactic and therapeutic procedures directed to prolong 
aging and improve quality of life. Multistrain metabolite constructions can predict 
perspective cellular formulas of multipro-/synbiotics for prophylaxis, supporting 
and accompanying therapy. Approaches developed are universal. They are useful in 
the study of any Gram-positive and eukaryotic (yeasts and yeast-like fungi) mono- 
and mixed cultures. The methodological principles proposed and described are of 
value for extended fields of clinical microbiology and medical bio-/nanotechnology.
Keywords: multistrain probiotics, probiotic lectins, glycoconjugates, 
microbiocenoses, antimicrobials
1. Introduction
Pro-/sym-/synbiotics are important objects of human microecology and medical 
biotechnology [1–4]. Microbes and human communicate each other by the way of 
recognition and binding glycoconjugates (GC) of varying pattern complexity by 
proteins (mainly adhesions and lectins) [5–9]. Lectin systems (LS) of symbiotic/
probiotic microorganisms (LSSM) recognizing GC represent new multifunctional 
factors [8–12]. LSSM are relatedly useful for human protein-/peptide-containing 
compounds and their complexes recognizing GC. LSSM reveal features of imitators 
of probiotics; members of new class of bacteriocin-like destructors of biofilms of 
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recognition and binding glycoconjugates (GC) of varying pattern complexity by 
proteins (mainly adhesions and lectins) [5–9]. Lectin systems (LS) of symbiotic/
probiotic microorganisms (LSSM) recognizing GC represent new multifunctional 
factors [8–12]. LSSM are relatedly useful for human protein-/peptide-containing 
compounds and their complexes recognizing GC. LSSM reveal features of imitators 
of probiotics; members of new class of bacteriocin-like destructors of biofilms of 
yeast-like fungal and Gram-positive pathogens; systems cofunctioning together 
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with enzymes of all known classes; and agents possessing antipathogenic synergism 
of different LS in antimicrobial combinations (between LS of Lactobacillus species 
and Bifidobacterium species, between genera Lactobacillus and Bifidobacterium, 
between LS of probiotic bacteria and lectins from medical plants, between LSSM 
and antibiotics) (see Table 2) [8, 9, 13, 14].
LS reveal significantly higher multifunctionality (antimicrobial, cytokine-like, 
others) and adaptive ability in surroundings in comparison to any component of 
LS. Applied prospects of LSSM in microbial associations of biotopes in the human 
body are of promised interest. LSSM and their reactive GC support balanced func-
tioning in organism in respect to evolutionary created mucosal organ-like infra-
structures of mutual interest for human and biotope microbiocenoses (MB) [12].
The purpose of the review is to evaluate our approaches in creation of probiotic 
metabolite compositions influencing and improving health of human biotope 
microbiocenoses. The data presented will be of interest for investigators in the fields 
of both medical microbiology and laboratory and industrial medical biotechnology.
2. Methods
Lactobacillus and Bifidobacterium strains were from the collection of microor-
ganisms of the normal microflora of G. N. Gabrichevsky Institute for Epidemiology 
and Microbiology, and probiotics Bifidin and Acilact were products of our institute. 
Bacteria were grown in media containing casein hydrolysate and yeast autolysate. 
LSSM were extracted from the protein fractions 27–220 kD using isoelectrofocusing 
(IEF) in a plate of polyacrylamide gel (PAG) in a gradient of pH 4–8. Identification 
of proteins was performed by electroblotting on a hydrophobic membrane and 
staining with SYPRO blot stain (Bio-Rad Lab.). Nonstained proteins were evaluated 
by other spectrophotometric methods. The distribution of LSSM among proteins 
was determined by treatment of blots with biotinylated GC (GC-b) containing 
multiple residues of sugar(s) linked to the polyacrylamide (PA) linear core (like 
in external phenotypes of mucins and mucin-type glycans) (www.lectinity.com; 
1. α/β-D-GalNAc-PA-b (animal mucins, T antigens)*
2. β-D-GalNAc-PA-b (animal mucins)
3. β-D-GlcNAc-PA-b (insect chitins and chitosans)
4. β-D-Gal-PA-b (plant or animal galactans)
5. β-D-Gal-3-sulfate-PA-b (acidic animal galactans)
6. α-D-Man-PA-b (yeast mannans)
7. α-D-Man-6P-PA-b (yeast phosphomannans)
8. α-L-Fuc-PA-b (fucans from brown algae)
9. α-L-Rha-PA-b (Gram-negative rhamnans)
10. MDP-PA-b (bacterial peptodoglycans)
11. Adi-PA-b (A-blood group substance GalNAcβ1-3GalβА1-)
12. Fs-PA-b (Forssman antigen GalNAcβ1-3GalNAcβА1-)
13. Tαα-PA-b (bacterial antigen Galα1-3GalNAcα1-)
*In brackets—natural substances which are imitated
Table 1. 
A list of synthetic GC used.
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Table 1) followed by final treatment with streptavidin-peroxidase conjugate. The 
bound peroxidase on the blot was registered in the presence of a chemiluminescent 
substrate in regime of a real time in the system BioChemi System (UVP, CA). 
Antimicrobial activities and synergism of LSSM, antibiotics, and phytolectins were 
tested on solid agar media during the prolonged growth and survival of communi-
cative fungal bodies (CFB) in the presence of disks of antimicrobials. Biosurfactants 
were tested and calculated using detection of sample drop activity against mineral 
oil film on water surface (the appearance of transparent circles). Amino acid com-
positions of samples were established using standard amino acid analyzer column 
chromatography. Oxidoreductase systems were detected on blots after IEF-PAG, 
resulting in kinetic protein stain disappearance (decolorization). Hydrolase systems 
were visually evaluated on blots after IEF-PAG (resulting in hydrolysis, splitting, 
and partial asymmetrical disappearance of protein bands). Maillard reaction 
products were partially evaluated as browning in culture supernatant according to 
optical density at 420 nm.
3. Results and discussion
3.1 Symbiotic lectins as system regulators and delivery agents
LSSM function as metabolomebiotics regulating metabolome according to the 
principle “LSSM network—whole organism metabolome network or interactome” 
[15]. The network of LSSM is created in the following manner: lectin molecule of 
determined molecular weight (in the Laemmli system) is represented by LS includ-
ing forms of varying charge and possessing a range of biological and physiological 
activities; such a minimal LS can be further transformed in a natural manner 
into extended network of complexes and supramolecular ensembles as a result of 
directional and sequential cascade binding of carbohydrates and GC. As a result of 
forming complexes and ensembles, lectin specificity of complexes and ensembles 
can be modified or changed during further development of recognition cascade 
network that will change the summary vector of specificity of LS. The latter will 
result in dynamic qualitative and quantitative changes of the local biotope sur-
rounding. Thus, the final whole resulting network of LSSM (as metabolomebiotics) 
will regulate the whole metabolome and interactome of organism involving human 
glycome (carbohydrates and GC: glycoproteins, glycoenzymes, glycolipids, recep-
tors, and others [16]). The metabolome possesses the ability to back direct and 
reversible effects of LSSM representing a part of hierarchic interactome. Multiple 
forms of adapted functioning LSSM microbiocenosis in the biotope will depend on 
the originality developed in a joint process of evolution involving host body local 
infrastructures for the distribution and disposition of microbiocenoses (organ-type 
constructions of both host and microbiocenosis interests are possible) [11, 12]. 
LSSM are ready to realize biologically active GC (as prebiotics, therapeutic agents, 
and metabiotics) in such symbiotic organs. The network of LSSM functions as 
noncellular simulators of symbiotics (probiotics) in the direct or indirect (through 
human higher hierarchic protection systems) predictable manners. For example, of 
communications between LSSM and own human protection systems, LSSM (as well 
as phytohemagglutinins from plants of medical significance) and artificial poly-
meric GC influenced peritoneal macrophage mobility in a coupled manner depend-
ing on doses of agents; LSSM were involved in modulation of cytokine production 
by human blood leukocytes [9, 17].
New useful properties of LSSM can be predicted and verified (cofunction-
ing to enzymes, adhesion, etc.), based on the fact that LSSM form a functional 
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superfamily of symbiotic lectins (on example of probiotic lectins and lectins of 
nitrogen-fixing bacteria). In addition, LSSM are members of the new class of 
destructors of biofilms of yeast-like and Gram-positive pathogens that simplify 
antimicrobial choice of components among LSSM. Other possibilities to operate 
with LSSM include their potential participation in a set of hierarchic pathways of 
advanced human innate protective systems in biotopes for cross talks. Both types 
of communications allow LSSM to be a successful synergistic assistant against 
pathogens in biotopes together with other antimicrobials and antimicrobial physi-
cal stress factors. As a result, LSSM reveal prolonged (early and late) anti-Candida 
activities as cascade (coupled) actions possibly influencing microecological niches 
of pathogens within biotope [registered during coculturing in the first 3 days (early 
events; also involving probiotic-like leader strains of L. acidophilus and L. casei), 
1–2 weeks, or 2–3 months (late events)] [18].
The used GC are characterized with known chemical structures simplifying 
interpretation and prognostics of results. Such GC reveal potential of metabiotics 
which may use LSSM as carriers [8, 12, 19]. As highly homogenous, synthetic GC 
better functionally imitate natural GC targets [bacterial proteoglycans, fungal 
(phosphor)mannans, others] important for antimicrobial/anti-infectious actions of 
LSSM. As a result, LSSM are very perspective in delivery and deposition of adequate 
specific GC which are locally releasing as therapeutics possessing anti-infectious, 
prebiotic, and/or communicative signal abilities and actions.
In biotopes LSSM participate in continuous (on-duty) support and periodical 
(biorhythmic) completion and exchange of normal GC décor of cells, tissues, and 
organs that must provide delaying or stopping further the development of the spot/
island/mosaic-landscape-originated and directed/metastasized abnormal processes 
as well as conserve any negative currently developmental events (initiation of 
appearance and survival of tumor-like cells as a result of innate intercellular com-
munications involving lectin receptor-coupled cell surface receptor mosaics).
LSSM (natural combinative sets of LSSM-GC complexes) influence all yeast-like 
fungal phases of life by prolonging the degradation and lysis of pathogenic micro-
biocenosis massifs or biofilms in human biotopes (on examples of Candida species). 
In respect to CFB functioning as niches, lectins of lactobacilli (LL as preferentially 
mucins/mucus-recognizing) and lectins of bifidobacteria (BL as preferentially 
mannan-recognizing) synergistically act against internal and peripheral subniche 
territories, respectively. The late destructive and lytic events in CFB may also take 
place due to LSSM cooperative complex action as metabolomebiotics together with 
hydrolases involved in pathogen destruction network. Synergistic actions between 
LSSM and other antifungals increase resulting in final (early or late [also of apop-
totic origin]) antipathogenic events as shown in Table 2 [20].
Endogenous LS antimicrobial actions (e.g., intestinal probiotic bifidobacterial 
and lactobacillar LS against intestinal yeast-like fungi) provide more directed, 
sensitive, and completed resulting effectiveness against pathogens (the primary 
absence and further late complete destruction of residual resistant colonies in 
external and internal regions of CFB of Candida albicans) compared to the action 
of phytolectin mixture from grasses of medical significance in the same condi-
tions. In cases of antibiotic-resistant strains, relatively sensitive to LSSM C. albi-
cans strain 547 (less potentially pathogenic compared to the strain 515, see below), 
the sorbed lactobacillar cationic LS revealed their synergistic ability to “regener-
ate” original anti-Candida effectiveness of antibiotic (on example of nystatin) 
in the internal region of CFB of yeast-like fungus (appearance of pathogen-free 
landscape connected to the border of the disk antibiotic). The phenomenon of 
synergistic reparation of the original ability of the sorbed antibiotic indicates 
prospects of additional mechanisms of LSSM combinative actions and partially 
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describes how to increase resulting antifungal effectiveness during prolonged 
contact to pathogenic CFB at fungal late steps. In the case of more resistant (poten-
tially “more pathogenic”) fungal strains (like C. albicans strain 515), the sorbed 
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(Not for C. tropicalis)
*Diffusion between disks placed on Sabouraud agar in Petri dishes (disk positions: p, peripheral; c, central; CR, 
central region, between p-disk and the center; PR, peripheral region, between p-disk and the border of agar). Disks 
included anionic (a) and cationic and (c) lactobacillar and bifidobacterial LSSM (aLL, cLL, aBL, cBL). MGBL as 
the mixture of the grass lectins from the mill of plants of medical significance: Potentilla album and Stellaria media. 
Lectins were used in subhemagglutinating doses (less 1 microgram/ml). Standard panel of disk antimycotics (HiMedia 
Lab. Pvt. Ltd.) was used. CFB, communicative fungal bodies.
Table 2. 
Antimicrobial synergism of LSSM and antibiotics.
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superfamily of symbiotic lectins (on example of probiotic lectins and lectins of 
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bifidobacterial cationic LS synergistically increased anti-Candida action of the 
grass phytolectin mixture.
Results indicate that LSSM may also participate in temporary separation and 
conservation of natural infectious biofilms to prevent early visual landscape 
development of diseases. The latter may be perspective as the assistant factor of 
improving quality of life (its prolongation, mucus and skin reparations, cosmetic 
significance, etc.) as it can be expected using symbiotics [21].
On the whole, our experimental approach (observations of antagonistic rela-
tionships between LSSM and pathogens in prolonged stress conditions) and the 
data obtained are supported by the conception describing microecological stress 
events in organism as the normal but sensor natural reactions [22].
3.2 The choice of strains and their consortia possessing potential for constructing 
new multistrain pro- and symbiotics
Screening, choice, and selection of new or improved antimicrobial and other 
useful properties of symbiotic (probiotic) cultural properties of strains and con-
sortia of human MB are important and strategic goals in prophylaxis and therapy of 
diseases, increasing resistance of organism and the acceleration of patient rehabili-
tation [1–4, 23]. Among GC investigated, glycans of mucin type (mucosal glycans) 
reveal special interest [24].
On the basis of own results, we proposed new algorithm of screening adequate 
probiotic-like microorganisms and their consortia possessing increased directed 
anti-infectious LS to construct new multipro-/sym-/synbiotics. The algorithm using 
LSSM (involving complexes to GC) among a panel of key factors in creating multi-
probiotics (MP) included (a) the choice of synthetic GC-imitating bacterial proteo-
glycans and (phospho)mannans of yeast-like fungi; (b) identification of different 
LSSM (GC-type-dependent) among proteins of cultural fluids of probiotic strain 
or consortium of strains; (c) comparison of (GC-type)-dependent LS (evaluation 
of summary LS intensity, length of LS distribution in pH-gradient tested, mosaic 
asymmetric configuration of distributed forms in LS, major forms as dominating 
in contribution to antimicrobial actions of LS, minor forms as expressing signal 
regulators of biorecognition in microbiocenoses, signals of communications to 
surrounding infrastructures, as well as additional participants of recognition of 
new types of biomarker GC); (d) identification of unique sets of components of LS 
significant for typing strains, species, or genera; (e) revealing and choice of com-
binative sets of potential antimicrobial forms of LS for further control and testing; 
and (f) control of antimicrobial activities initiated, supported, and/or influenced 
by LS-containing preparations in other (nondependent) methods.
The data which were useful for constructing any multiprobiotics (Acilact-like) is 
presented in Table 3.
In Table 3 the data needed for constructing formulas of any MP are presented on 
example of strain component compositions of Acilact (the well-known MP which 
served as a model). Algorithm for constructing formulas includes a few steps:
The first step: For formulas of any MP of category A (formulas as sum of wishful 
selected superiorities): the choice of all parameters of superiorities of MP (No. 4 as 
MP in code notes: positions 1.3, 1.4, 1.6, 2.7, 2.8, 2.13, 2.14, 2.15, and 4.3; major ingre-
dient strain contributors are at the second position in the code sequences [from left 
to right] position in code).
The second step: For formulas of any MP of category B: accounting additional 
superiorities of MP [No. 4 as MP in code notes; selected minimal positions of 
parameters for No. 4 in sequence indicate maximal expression of the contrary 
(by implicity) parameters]. For example, in the case of No. 4 in codes 1.1 
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No. Parameters of supernatants, ranging MP and its strains, proposals (P) Code ranging MP 
and its strains*
1 Status of proteins
1.0 Content of partially hydrolyzed protein
K3III24 > MP > 100 ash > NK1
P: K3III24 as the main source of active or signal oligopeptides
3. 4. 2. 1.
1.1 Acidic proteins pI 4–5
NK1 > 100 ash > K3III24 > MP
P: NK1 as the main source of basis cytoagglutinating and adhesive agents 
coupled to a spectrum of biological activities
1. 2. 3. 4.
1.2 Cationic proteins pI 7–8
NK1 > K3III24 > 100 ash > MP
P: Strains and their combinations as sources of lectins and lectin-like agents 
coupled to exopolymeric substances of compounds
1. 3. 2. 4.
1.3 Oxidase-reductase systems pI 5–5.5
MP > 100 ash > K3III24 > NK1[absence]
P: NK1 without extracellular major oxidoreductase systems
4. 2. 3. 1.
1.4 Hydrolase systems
MP > K3III24 > 100 ash > NK1
P: NK1 without extracellular major hydrolases (caseinases, peptidases, 
others)
4. 3. 2. 1.
1.5 Level of aggregation upon storing concentrates
K3III24 > 100 ash > NK1 > MP[no aggregation]
P: Irreversibility for K3III24 (similar to red cell biofilm storing)
3. 2. 1. 4.
1.6 Ability in membrane ultrafiltration
MP > NK1 > 100 ash > K3III24
P: Technological advantage of MP as mixture of strains (mixture of strains 
is needed)
4. 1. 2. 3.
2 Status of amino acids
2.0 Production of amino acids
NK1 > K3III24 > MP > 100 ash
P: Low antagonism between certain strains within MP can be under 
consideration upon strain choice
1. 3. 4. 2.
2.1 Tyr (sites for serine proteinases, fluorophores)
K3III24 > 100 ash > MP > NK1
P: Tyr can serve as criterion of utilization of fluorophores
3. 2. 4. 1.
2.2 Phe (sites for serine proteinases, fluorophores)
NK1 > MP > K3III24 > 100 ash
P: Support of point 2, revealing mechanism for point 2
1. 4. 3. 2.
2.3 Fluorophores (Trp, Tyr) (excitation at 254 nm)
100 ash > K3III24 > NK1 > MP
P: Dominated contribution of Tyr and their derivatives
2. 3. 1. 4.
2.3.1 Fluorophores (excitation at 365 nm)
100 ash > K3III24 > NK1 > > MP
P: Degradation/ utilization in MP (fluorophores cannot be used as targets)
2 3 1 4
2.4 Gly (hydrophobic, anti-adhesion action)
NK1 > MP > K3III24 > 100 ash
P: Gly as natural additive to improve signal activities and communications
1. 4. 3. 2.
2.5 Leu (hydrophobic, site for peptidases)
(Parameter is slightly dependent on strain origin)
K3III24 > 100 ash > MP, NK1
3. 2. ¼**. 4/1.
2.6 Ile (hydrophobic, participation in synthesis of biologically active volatile 
fatty acids)
K3III24 > 100 ash > MP > NK1
3. 2. 4. 1.
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No. Parameters of supernatants, ranging MP and its strains, proposals (P) Code ranging MP 
and its strains*
2.7 Ala (partially from peptidoglycans, site for exopeptidases)
MP > K3III24, 100 ash > NK1
P: Antagonism between strains results in partial cell wall degradation in MP
4. 2/3. 3/2. 1.
2.8 Ser (sites for hydrolase splitting and O-glycosylation)
MP > K3III24 > 100 ash > NK1
P: Support of point 1.4
4. 3. 2. 1.
2.9 Thr (site for O-glycosylation)
NK1 > 100 ash > MP > K3III24
P: Thr as criterion for evaluation of metabolism of cluster square positions 
for recognition in proteins (in comparison to point 2.8)
1. 2. 4. 3.
2.10 Lys (from cationic poly/oligopeptides, site for serine
proteinases, participation in Maillard reaction)
MP > 100 ash > K3III24 > NK1
P: Support of point 1.4
4. 2. 3. 1.
2.11 Val (hydrophobic, participation in synthesis of biologically active volatile 
fatty acids)
K3III24 > 100 ash > NK1 > MP
P: Mostly important criterion concerning volatile fatty acids producing
3. 2. 1. 4.
2.12 Glu/Gln (also as sites for amidases)
NK1 > MP, K3III24 > 100 ash
1. 4. 3. 2.
2.13 Asp/Asn (sites for amidases and N-glycosylation)
MP, 100 ash > NK1 > K3III24
P: Partial support of point 1.4
4. 2. 1. 3.
2.14 His (participation in auto-oxidation of protein, high affinity to metal 
cations, activation of oxidases and heme)
MP > NK1 > 100 ash > K3III24
P: Potential for metal chelate affinity chromatography and immobilization 
(for microassays)
4. 1. 2. 3.
2.15 Arg (from cationic poly[oligo]peptides, destruction
during pigments forming in Maillard reaction)
MP > NK1 > K3III24 > 100 ash
P: One of the way of decolorization of MP
4. 1. 3. 2.
2.16 Met (antioxidant)
NK1 > MP > K3III24 > 100 ash
1. 4. 3. 2.
2.17 Cys2 disulfide bonds (oxidation of SH-groups into Cys2)
K3III24 > NK1 > MP > 100 ash[not observed]
3. 1. 4. 2.
2.18 Pro (Pro-bends in regular structures of proteins)
100 ash > MP > K3III24 > NK1[traces]
2. 4. 3. 1.
3 Status of biosurfactants
3.0 Associated biosurfactants in complexes >27 kD
NK1 > MP > > 100 ash > K3III24
P: NK1 as the main source of movable permeable (detergent like) complex 
effectors; support point 4.3
1. 4. 2. 3.
3.1 Biosurfactants active against mineral oil
K3III24 > MP > 100 ash > NK1




P: K3III24 needs combination to any other strain to increase cultural 
components (>27 kD) to be emulsified
2. 1. 4. 3.
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(maximal resulting hydrolytic activities in respect to acidic proteins; increased 
level of antimicrobial peptides), 1.2 (maximal resulting hydrolytic activities in 
respect to cationic proteins; increased level of antimicrobial peptides including 
bacteriocin-like), 1.5 (the minimal level of aggregation upon storing concen-
trates), 2.3 (the minimal level of fluorophores exciting at 254 nm; contribution 
of Tyr and Trp or their derivatives), 2.3.1 (the minimal level of fluorophores 
exciting at 365 nm; contribution of Trp); and 4.2 (the minimal level of colored 
products); the major ingredient strain contributors are accounted as the third 
position in code.
The third step: The final formulas (formulas of category C) include combinations 
of formulas A and B. Multifunctionality of parameters analyzed can be extended 
(as in cases of amino acids [25]).
Extended approach for constructing more adaptive mixtures of lactobacillar 
and bifidobacterial MP (on the basis of Acilact extended by accounting industrial 
bifidobacterial strains) is presented in Table 4.
As expected, taxonomically mixed probiotics (symbiotics) will possess 
increased survival in biotopes of human organism. The same principles and 
algorithm (as for formulas of Acilact variants described above) can be applied. 
Combinations of Acilact ingredient strains and ingredients of Bifidin (B. longum 
spp. adolescentis MS-42), Bioprotectin (B. bifidum No. 1), and other bifidobacterial 
probiotics produced in Russia are of priority interest (also due to the possibility of 
their usage as standard models).
Table 4 demonstrates algorithm of further passage from intra-genus cases 
(Lactobacillus) of Gram-positive MP to inter-genus cases of MP as combinations of 
probiotic lactobacilli and bifidobacteria of the human gut origin.
Selective sets of parameters (points in Table 4) indicate principle differences 
between lactobacilli and bifidobacteria (as blocks of lactobacillar and bifidobacte-
rial strains in 7-mark code). Completing lactobacillar/bifidobacterial synergism 
is expected and predicted. Selected combinations of strains from both blocks can 
be used for creation of directed MP. Other more complex cases include unblocked 
lactobacillar and bifidobacterial sequences within the code (additional prognostic 
conclusions are possible). Code positions “1” and “5” (both strains produce high 
levels of cytoagglutinating LS) reveal adjacent/similar behavior that indicates high 
level of compatibility of the strains NK1 and MS42.
No. Parameters of supernatants, ranging MP and its strains, proposals (P) Code ranging MP 
and its strains*
4.2 Pigment products [optical density at 420 nm]
K3III24 > NK1 > 100 ash > MP
P: K3III24 as the main potential source of neoglycoconjugates of 
nonenzymatical origin; MP as maximally decolorized product needed 
cofunctioning strain mixture; partial inverse correlation to point 1.3
3. 1. 2. 4.
4.3 Antimicrobial activity (toward a panel of diagnostic mainly Gram-negative 
bacteria)
MP > NK1 > 100 ash > K3III24
P: Support point 3; potential of K3III24 to other targets (against Gram-
positive bacteria and fungi)
4. 1. 2. 3.
*1, NK1 (Lactobacillus helveticus NK1); 2, 100 ash (L. helveticus 100 ash); 3, K3III24 (L. casei K3III24);  
4, multiprobiotic (MP) on example of variants of Acilact.
**Alternative positions.
Table 3. 
Strain code ranging for multiprobiotic construction on example of Acilact (the Lactobacillus multistrain 
probiotic).
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No. Parameters of supernatants, ranging MP and its strains, proposals (P) Code ranging MP 
and its strains*
2.7 Ala (partially from peptidoglycans, site for exopeptidases)
MP > K3III24, 100 ash > NK1
P: Antagonism between strains results in partial cell wall degradation in MP
4. 2/3. 3/2. 1.
2.8 Ser (sites for hydrolase splitting and O-glycosylation)
MP > K3III24 > 100 ash > NK1
P: Support of point 1.4
4. 3. 2. 1.
2.9 Thr (site for O-glycosylation)
NK1 > 100 ash > MP > K3III24
P: Thr as criterion for evaluation of metabolism of cluster square positions 
for recognition in proteins (in comparison to point 2.8)
1. 2. 4. 3.
2.10 Lys (from cationic poly/oligopeptides, site for serine
proteinases, participation in Maillard reaction)
MP > 100 ash > K3III24 > NK1
P: Support of point 1.4
4. 2. 3. 1.
2.11 Val (hydrophobic, participation in synthesis of biologically active volatile 
fatty acids)
K3III24 > 100 ash > NK1 > MP
P: Mostly important criterion concerning volatile fatty acids producing
3. 2. 1. 4.
2.12 Glu/Gln (also as sites for amidases)
NK1 > MP, K3III24 > 100 ash
1. 4. 3. 2.
2.13 Asp/Asn (sites for amidases and N-glycosylation)
MP, 100 ash > NK1 > K3III24
P: Partial support of point 1.4
4. 2. 1. 3.
2.14 His (participation in auto-oxidation of protein, high affinity to metal 
cations, activation of oxidases and heme)
MP > NK1 > 100 ash > K3III24
P: Potential for metal chelate affinity chromatography and immobilization 
(for microassays)
4. 1. 2. 3.
2.15 Arg (from cationic poly[oligo]peptides, destruction
during pigments forming in Maillard reaction)
MP > NK1 > K3III24 > 100 ash
P: One of the way of decolorization of MP
4. 1. 3. 2.
2.16 Met (antioxidant)
NK1 > MP > K3III24 > 100 ash
1. 4. 3. 2.
2.17 Cys2 disulfide bonds (oxidation of SH-groups into Cys2)
K3III24 > NK1 > MP > 100 ash[not observed]
3. 1. 4. 2.
2.18 Pro (Pro-bends in regular structures of proteins)
100 ash > MP > K3III24 > NK1[traces]
2. 4. 3. 1.
3 Status of biosurfactants
3.0 Associated biosurfactants in complexes >27 kD
NK1 > MP > > 100 ash > K3III24
P: NK1 as the main source of movable permeable (detergent like) complex 
effectors; support point 4.3
1. 4. 2. 3.
3.1 Biosurfactants active against mineral oil
K3III24 > MP > 100 ash > NK1




P: K3III24 needs combination to any other strain to increase cultural 
components (>27 kD) to be emulsified
2. 1. 4. 3.
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(maximal resulting hydrolytic activities in respect to acidic proteins; increased 
level of antimicrobial peptides), 1.2 (maximal resulting hydrolytic activities in 
respect to cationic proteins; increased level of antimicrobial peptides including 
bacteriocin-like), 1.5 (the minimal level of aggregation upon storing concen-
trates), 2.3 (the minimal level of fluorophores exciting at 254 nm; contribution 
of Tyr and Trp or their derivatives), 2.3.1 (the minimal level of fluorophores 
exciting at 365 nm; contribution of Trp); and 4.2 (the minimal level of colored 
products); the major ingredient strain contributors are accounted as the third 
position in code.
The third step: The final formulas (formulas of category C) include combinations 
of formulas A and B. Multifunctionality of parameters analyzed can be extended 
(as in cases of amino acids [25]).
Extended approach for constructing more adaptive mixtures of lactobacillar 
and bifidobacterial MP (on the basis of Acilact extended by accounting industrial 
bifidobacterial strains) is presented in Table 4.
As expected, taxonomically mixed probiotics (symbiotics) will possess 
increased survival in biotopes of human organism. The same principles and 
algorithm (as for formulas of Acilact variants described above) can be applied. 
Combinations of Acilact ingredient strains and ingredients of Bifidin (B. longum 
spp. adolescentis MS-42), Bioprotectin (B. bifidum No. 1), and other bifidobacterial 
probiotics produced in Russia are of priority interest (also due to the possibility of 
their usage as standard models).
Table 4 demonstrates algorithm of further passage from intra-genus cases 
(Lactobacillus) of Gram-positive MP to inter-genus cases of MP as combinations of 
probiotic lactobacilli and bifidobacteria of the human gut origin.
Selective sets of parameters (points in Table 4) indicate principle differences 
between lactobacilli and bifidobacteria (as blocks of lactobacillar and bifidobacte-
rial strains in 7-mark code). Completing lactobacillar/bifidobacterial synergism 
is expected and predicted. Selected combinations of strains from both blocks can 
be used for creation of directed MP. Other more complex cases include unblocked 
lactobacillar and bifidobacterial sequences within the code (additional prognostic 
conclusions are possible). Code positions “1” and “5” (both strains produce high 
levels of cytoagglutinating LS) reveal adjacent/similar behavior that indicates high 
level of compatibility of the strains NK1 and MS42.
No. Parameters of supernatants, ranging MP and its strains, proposals (P) Code ranging MP 
and its strains*
4.2 Pigment products [optical density at 420 nm]
K3III24 > NK1 > 100 ash > MP
P: K3III24 as the main potential source of neoglycoconjugates of 
nonenzymatical origin; MP as maximally decolorized product needed 
cofunctioning strain mixture; partial inverse correlation to point 1.3
3. 1. 2. 4.
4.3 Antimicrobial activity (toward a panel of diagnostic mainly Gram-negative 
bacteria)
MP > NK1 > 100 ash > K3III24
P: Support point 3; potential of K3III24 to other targets (against Gram-
positive bacteria and fungi)
4. 1. 2. 3.
*1, NK1 (Lactobacillus helveticus NK1); 2, 100 ash (L. helveticus 100 ash); 3, K3III24 (L. casei K3III24);  
4, multiprobiotic (MP) on example of variants of Acilact.
**Alternative positions.
Table 3. 
Strain code ranging for multiprobiotic construction on example of Acilact (the Lactobacillus multistrain 
probiotic).
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Further constructing other or extended multistrain symbiotics is depended on 
choice of important parameters of interest (to increase the number of comparable 
codes used in Tables 3 and 4). Important prospects in constructing taxonomically 
mixed symbiotic formulas are expected on the basis of identified LSSM sets of the 
strains as counted ingredients of multisymbiotic as well as evaluation of the rela-
tive contribution of LSSM types in resulting multifunctional activities of mixed 
product. For example, the general properties of LS of lactobacilli and bifidobacteria 
investigated by us are “recognition of mucin-type targets” more or less than “recog-
nition of mannan-type targets” for LL or BL, respectively [8]. As a result, LSSM-
dependent synergism (which can be directed and predicted using extended panel of 
GC for LSSM selection and choice) of new taxonomically mixed symbiotics can be 
achieved.




1 Antifreeze components >27 kD, pI 4–8
(against any type of crystal forming during IEF-PAG):
gall > bif1 > MS42 > NK1 > MP > K3III24, 100 аsh
P: bifidobacterial C for stabilization of K3III24 and 100 аsh
7. 6. 5. 1. 4. 
3/2*. 2/3.
2 Formation of organic crystals in the presence of components >27 kD
(in conditions of 7М urea, 5% saccharose, 8°С, night, IEF in slab of PAG):
рI 4–6: 3III24, 100 аsh > MP > NK1 > MS > bif1 > gall (not)
pI 6–8: K3III24, 100 аsh > MP > NK1 > gall>bif1 > MS42
P: Potential approach to micro- and nanoassembling effectors
2/3. 3/2. 4. 
1. 5. 6. 7.
2/3. 3/2. 4. 
1. 7. 6. 5.
3 Complex protein C > 27 kD:
pI 4–6: NK1 > MS42 > K3III24 > gall> 100 аsh > bif1 > MP
pI 6–8: NK1 > gall > K3III24 > MS42 > 100 аsh > MP > bif1
P: Donors of cationic bacteriocin-like associates with exopolymeric compounds
1. 5. 3. 7. 2. 
6. 4.
1. 7. 3. 5. 2. 
4. 6.
4 Adhesins as colorless transparent not water-soluble drops on
polystyrene (number of drops):
gall > MS42 > NK1 > bif1 > MP > K3III24 = 100 аsh(not)
P: The size and numbers of drops indicate level of emulsification of C compared to 
original supernatant




P: C “NK1 + gall” and “NK1 + bif1” as synergistic antimicrobials
6. 7. 3. 4. 2. 
5. 1.
6 LSSM as mucin-binding:
pI 4–5.5: gall > MP > NK1 > MS42 > bif1 > K3III24, 100 аsh
pI 5.5–8: MS42 > bif1 > gall > NK1 > MP > 100 аsh, K3III24
P: C for delivery into intestinal and urogenital mucosal cavities
7. 4. 1. 5. 6. 
2/3. 3/2.
5. 6. 7. 1. 4. 
2/3. 3/2.
7 LSSM as mannan-binding:
pI 4–5.5: 100 аsh, K3III24 > NK1 > MS42 > gall > MP > bif1
pI 5.5–8: gall > bif1 > MS42 > NK1 > MP > 100 аsh, K3III24
P: Potential against eukaryotic (yeast and yeast-like), prokaryotic (staphylococci), 
and HIV/HIV-related infections; delivery into cell and cell organelles
2/3. 3/2. 1. 
5. 7. 4. 6.
7. 6. 5. 1. 4. 
2/3. 3/2.
1, NK1 (L. helveticus NK1); 2, 100 ash (L. helveticus 100 ash); 3, K3III24 (L. casei K3III24); 4, MP (Acilact); 
5, MS42 (B. adolescentis МS42); 6, bif1 (B. bifidum No. 1); 7, gall (B. gallinarum GB); C, concentrate 
(>27 kD) of cultural fluid supernatant; IEF, isoelectrofocusing; PAG, polyacrylamide gel; P, prognostic proposals; 
*Alternative position. Blocks of lactobacillar (boldface) and bifidobacterial (italic font) strains are shown.
Table 4. 
Strain code ranging for multiprobiotic construction on example of new multiprobiotics including bifidobacteria 
and lactobacilli.
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Universality of approach proposed in Table 4 means that the panel of com-
parative parameters of investigation is unlimited for selection. As advantages of 
this approach for creation of perspective formulas of multipro-/symbiotics, some 
properties of future combinative products can be predicted and verified.
Aforementioned codes (Tables 3 and 4) extend the potential of using tradi-
tional MP. Results open new possibilities for investigation of LSSM types among 
strains and constructed consortia to develop perspective GC-type-dependent LSSM 
combinations possessing needed actions toward human interactome. In terms of 
personalized medicine, individual LSSM applications are of reality. For example, 
LSSM could be applied as “a functional tissue biotope” or mucosal organ-specific 
agents and organizers of lectin-coupled reactions and activities [26, 27].
3.3 Anaerobic synergistic preparations containing LSSM for support of human 
protective systems
Due to high distribution in organism, oxidative stress (as the power destruc-
tive factor initiating diseases) needs the constant presence of the power protec-
tive antioxidant systems [28, 29]. Some therapeutic proteins regulating cellular 
consumption of oxygen can be involved into development of tumor and other 
side pathologies in organism. We isolated system anaerobic (without oxidases 
initiating of oxygen and peroxide radicals) preparations of acidic/anionic and 
alkaline/cationic LSSM from cultures of symbiotic (probiotic) industrial strains of 
human bifidobacteria and lactobacilli as consortia that were successfully applied. 
Such preparations devoid the ability to induce destructive oxidative stress (cross-
linking and inactivation of therapeutic proteins, etc.) in respect to surrounding 
infrastructures.
The used synthetic GC in our work were characterized with antioxidant prop-
erties in respect to LS as carriers of GC (prolongation of chemiluminescence of 
protective complexes was observed). Similar resulting protection of LSSM was also 
registered in the presence of neutral and cationic bifidobacterial and lactobacillar 
cultural exopolymeric compounds (EPC) of nonprotein origin (as observed on 
the blot after IEF-PAG). Acidic and alkaline anaerobic LS of bifidobacteria and 
lactobacilli revealed the following general antipathogenic actions: (a) own and 
overlapped/synergistic; (b) toward communicative bodies of microbial massifs 
and biofilms of the potentially pathogenic yeast-like fungi and Gram-positive 
bacteria. All four types of preparations of LSSM used were characterized by own 
mechanisms of antimicrobial actions in comparison to action of other antimicrobial 
systems (antibiotics, bacteriocins, phytolectins, subisotype products of isotypes 
С4В and С4А of the human complement component C4) [30, 31]. LS from human 
probiotic bacterial cultures revealed the ability to act as cascades in such reactions 
as initiation/changing or switching recognition of GC of different types (imita-
tors of mannans, mucins, components of bacterial walls, Forssman antigens, Tn, 
blood group substance A) using the same original pool of lectin forms of taken 
multistrain probiotic. The presence of cations Ru2+ (ingredient of SYPRO involved 
in photosensibilization) strongly increased discreteness and number of forms of 
acidic lectins—potential carriers and deliveries of GC. Stability of obtained mosaic 
asymmetric landscape pictures of the systems LSSM-GC as multistrain probiotic-
depending and multistrain probiotic-supporting biotope balance of recognition 
and reversible retaining/depositing of GC (therapeutics, biomarkers, others) was 
observed. Combinations of anaerobic LS-containing proteins revealed themselves 
in respect to yeast-like and Gram-positive pathogenic targets as more selective in 
the choice of the adequate regional territory of massif of pathogen and limitation of 
early and late time (depending on localization of targeted region of communicative 
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Further constructing other or extended multistrain symbiotics is depended on 
choice of important parameters of interest (to increase the number of comparable 
codes used in Tables 3 and 4). Important prospects in constructing taxonomically 
mixed symbiotic formulas are expected on the basis of identified LSSM sets of the 
strains as counted ingredients of multisymbiotic as well as evaluation of the rela-
tive contribution of LSSM types in resulting multifunctional activities of mixed 
product. For example, the general properties of LS of lactobacilli and bifidobacteria 
investigated by us are “recognition of mucin-type targets” more or less than “recog-
nition of mannan-type targets” for LL or BL, respectively [8]. As a result, LSSM-
dependent synergism (which can be directed and predicted using extended panel of 
GC for LSSM selection and choice) of new taxonomically mixed symbiotics can be 
achieved.




1 Antifreeze components >27 kD, pI 4–8
(against any type of crystal forming during IEF-PAG):
gall > bif1 > MS42 > NK1 > MP > K3III24, 100 аsh
P: bifidobacterial C for stabilization of K3III24 and 100 аsh
7. 6. 5. 1. 4. 
3/2*. 2/3.
2 Formation of organic crystals in the presence of components >27 kD
(in conditions of 7М urea, 5% saccharose, 8°С, night, IEF in slab of PAG):
рI 4–6: 3III24, 100 аsh > MP > NK1 > MS > bif1 > gall (not)
pI 6–8: K3III24, 100 аsh > MP > NK1 > gall>bif1 > MS42
P: Potential approach to micro- and nanoassembling effectors
2/3. 3/2. 4. 
1. 5. 6. 7.
2/3. 3/2. 4. 
1. 7. 6. 5.
3 Complex protein C > 27 kD:
pI 4–6: NK1 > MS42 > K3III24 > gall> 100 аsh > bif1 > MP
pI 6–8: NK1 > gall > K3III24 > MS42 > 100 аsh > MP > bif1
P: Donors of cationic bacteriocin-like associates with exopolymeric compounds
1. 5. 3. 7. 2. 
6. 4.
1. 7. 3. 5. 2. 
4. 6.
4 Adhesins as colorless transparent not water-soluble drops on
polystyrene (number of drops):
gall > MS42 > NK1 > bif1 > MP > K3III24 = 100 аsh(not)
P: The size and numbers of drops indicate level of emulsification of C compared to 
original supernatant




P: C “NK1 + gall” and “NK1 + bif1” as synergistic antimicrobials
6. 7. 3. 4. 2. 
5. 1.
6 LSSM as mucin-binding:
pI 4–5.5: gall > MP > NK1 > MS42 > bif1 > K3III24, 100 аsh
pI 5.5–8: MS42 > bif1 > gall > NK1 > MP > 100 аsh, K3III24
P: C for delivery into intestinal and urogenital mucosal cavities
7. 4. 1. 5. 6. 
2/3. 3/2.
5. 6. 7. 1. 4. 
2/3. 3/2.
7 LSSM as mannan-binding:
pI 4–5.5: 100 аsh, K3III24 > NK1 > MS42 > gall > MP > bif1
pI 5.5–8: gall > bif1 > MS42 > NK1 > MP > 100 аsh, K3III24
P: Potential against eukaryotic (yeast and yeast-like), prokaryotic (staphylococci), 
and HIV/HIV-related infections; delivery into cell and cell organelles
2/3. 3/2. 1. 
5. 7. 4. 6.
7. 6. 5. 1. 4. 
2/3. 3/2.
1, NK1 (L. helveticus NK1); 2, 100 ash (L. helveticus 100 ash); 3, K3III24 (L. casei K3III24); 4, MP (Acilact); 
5, MS42 (B. adolescentis МS42); 6, bif1 (B. bifidum No. 1); 7, gall (B. gallinarum GB); C, concentrate 
(>27 kD) of cultural fluid supernatant; IEF, isoelectrofocusing; PAG, polyacrylamide gel; P, prognostic proposals; 
*Alternative position. Blocks of lactobacillar (boldface) and bifidobacterial (italic font) strains are shown.
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Strain code ranging for multiprobiotic construction on example of new multiprobiotics including bifidobacteria 
and lactobacilli.
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Universality of approach proposed in Table 4 means that the panel of com-
parative parameters of investigation is unlimited for selection. As advantages of 
this approach for creation of perspective formulas of multipro-/symbiotics, some 
properties of future combinative products can be predicted and verified.
Aforementioned codes (Tables 3 and 4) extend the potential of using tradi-
tional MP. Results open new possibilities for investigation of LSSM types among 
strains and constructed consortia to develop perspective GC-type-dependent LSSM 
combinations possessing needed actions toward human interactome. In terms of 
personalized medicine, individual LSSM applications are of reality. For example, 
LSSM could be applied as “a functional tissue biotope” or mucosal organ-specific 
agents and organizers of lectin-coupled reactions and activities [26, 27].
3.3 Anaerobic synergistic preparations containing LSSM for support of human 
protective systems
Due to high distribution in organism, oxidative stress (as the power destruc-
tive factor initiating diseases) needs the constant presence of the power protec-
tive antioxidant systems [28, 29]. Some therapeutic proteins regulating cellular 
consumption of oxygen can be involved into development of tumor and other 
side pathologies in organism. We isolated system anaerobic (without oxidases 
initiating of oxygen and peroxide radicals) preparations of acidic/anionic and 
alkaline/cationic LSSM from cultures of symbiotic (probiotic) industrial strains of 
human bifidobacteria and lactobacilli as consortia that were successfully applied. 
Such preparations devoid the ability to induce destructive oxidative stress (cross-
linking and inactivation of therapeutic proteins, etc.) in respect to surrounding 
infrastructures.
The used synthetic GC in our work were characterized with antioxidant prop-
erties in respect to LS as carriers of GC (prolongation of chemiluminescence of 
protective complexes was observed). Similar resulting protection of LSSM was also 
registered in the presence of neutral and cationic bifidobacterial and lactobacillar 
cultural exopolymeric compounds (EPC) of nonprotein origin (as observed on 
the blot after IEF-PAG). Acidic and alkaline anaerobic LS of bifidobacteria and 
lactobacilli revealed the following general antipathogenic actions: (a) own and 
overlapped/synergistic; (b) toward communicative bodies of microbial massifs 
and biofilms of the potentially pathogenic yeast-like fungi and Gram-positive 
bacteria. All four types of preparations of LSSM used were characterized by own 
mechanisms of antimicrobial actions in comparison to action of other antimicrobial 
systems (antibiotics, bacteriocins, phytolectins, subisotype products of isotypes 
С4В and С4А of the human complement component C4) [30, 31]. LS from human 
probiotic bacterial cultures revealed the ability to act as cascades in such reactions 
as initiation/changing or switching recognition of GC of different types (imita-
tors of mannans, mucins, components of bacterial walls, Forssman antigens, Tn, 
blood group substance A) using the same original pool of lectin forms of taken 
multistrain probiotic. The presence of cations Ru2+ (ingredient of SYPRO involved 
in photosensibilization) strongly increased discreteness and number of forms of 
acidic lectins—potential carriers and deliveries of GC. Stability of obtained mosaic 
asymmetric landscape pictures of the systems LSSM-GC as multistrain probiotic-
depending and multistrain probiotic-supporting biotope balance of recognition 
and reversible retaining/depositing of GC (therapeutics, biomarkers, others) was 
observed. Combinations of anaerobic LS-containing proteins revealed themselves 
in respect to yeast-like and Gram-positive pathogenic targets as more selective in 
the choice of the adequate regional territory of massif of pathogen and limitation of 
early and late time (depending on localization of targeted region of communicative 
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body of pathogen) for the mostly effective visible actions of LS, obtaining uniform 
pure landscapes of LSSM action on massif of Candida albicans (the absence or 
minimization of LSSM-resistant residual fungal colonies in the interacting intestine 
system “LS of human intestinal bifidobacteria and lactobacilli—human intestinal 
C. albicans”). Antimicrobial activities of LSSM and phytolectins (phytohemagglu-
tinin from the kidney bean) could be realized not only directly but also through the 
influence (together with synthetic mannans and mucins) in respect to macrophage 
migration as well as through inducing production of cytokines by stimulated blood 
lymphocytes (on the example of tumor necrosis factor-α). Results indicate pros-
pects of anaerobic LSSM as assistant ingredients of the possible drug forms.
3.4 Synbiotic minibioreactor using LSSM for screening GC
During the last time, synbiotics and symbiotics (as synergistic sum of probiotics 
and prebiotics) are of increased investigator interest due to their antimicrobial and 
other useful reactions [1, 2]. In this respect LSSM represent new class of antipatho-
genic proteins (possessing extended potential of application) which recognize dif-
ferent GC. LSSM represent multifunctional potential of relatively highly molecular 
mass polymeric metabolites of cultures of the human microbiota (microbiocenoses) 
and consortia (also multistrain probiotics) of human indigenous microorganisms. 
LSSM cofunction together with artificial and biologically active natural GC [32].
According to own results, we proposed suitable laboratory minisystem for 
screening prebiotic and therapeutical GP using LSSM and sterile heparinized insulin 
syringes of 1 ml volume. The following results were obtained: (1) LSSM-containing 
fraction stimulated production of both the whole and adhesive mass of bifidobacteria, 
(2) LiCl (15 mM and higher) increased dose depending on the number of adhesive 
colonies, (3) bifidobacterial LSSM (within pI 4–4.5) were characterized with strong 
affinity to anionic synthetic GC (possessing exposed residues of sulfated galactosides 
or, in a less extent of affinity, exposed residues of mannose-6-phosphates), and 
(4) sulfated glycosaminoglycans together with cations Li+ and LSSM as potential car-
riers of Li+ participated in functioning bioreactor imitating synbiotope (multiplication 
of bifidobacterial colonies and their survival were observed).
Proposed synbiotic system is perspective for screening prebiotic GC (as it is 
known for prebiotic derivatives of chitin, chitosan, fucoidan, and glycopeptides 
[33, 34]). Table 1 includes potential prebiotic sources such as chitin and α-L-fucan 
which react to LSSM (LSSM may serve carriers of metabiotic GC; the list of GC can 
be unlimitedly extended).
3.5 Membrane technological prospects of LSSM
Progress in membrane and solid-phased technologies using LS-GC interactions 
includes the potential of their application in microassays, biochips (membrane 
bound glycoarrays or lectin arrays), and biosensors [35, 36].
The use of affine pore hydrophobic (uncharged) membranes predictably 
covered with mosaics of multifunctional sets of LSSM (additional significant 
purification of LSSM on membranes is reached) allows prolonged storing LSSM 
without decreasing samples in activities. The following prospects of LSSM-GC 
combinations may be of practical interest: (a) antifungal covers of prolonged action 
in combination with antibiotics and physical factors of stress [radiation (ultra-
violet and ultrasonic), light (biorhythm “day-night”), temperature, pH, oxygen, 
season changes (also biorhythmic), others] and (b) chemiluminescent systems 
cofunctioning in regime of real time for medical and industrial biotechnology and 
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bionanotechnologies [our results include the following coupled systems: “low acidic 
LSSM, low acidic oxidoreductases of lactobacilli”; “alkaline bifidobacterial LS, alka-
line bifidobacterial exopolymeric compounds”; “neutral lactobacillar/bifidobacte-
rial LS, neutral lactobacillar/bifidobacterial biosurfactants”; “LS, strongly acidic  
(pI 3–4) serial phyto-oxidoreductases/phyto[glycosyl]oxidases”].
Membrane technologies using separated proteins, oligopeptides, and their com-
plexes (especially) together with intrinsic or exogenic (SYPRO dye) fluorescence 
registered in live bioimagination are especially sensitive and perspective (protein band 
discreteness using fluorescence technique was better compared to the chemilumi-
nescence technique). The latter allows identification stabile boundaries of the whole 
protein massifs for further establishment of LSSM and other biologically and physi-
ologically active components among protein mosaics. Bioluminescence (fluorescent 
technique in combination with chemiluminescence technique) in optimal (depending 
on the object and the goal of study) conditions allows express-ranging cultural fluid 
groups of proteins and LS according to molecular mass (for additional standardization 
and typing of strains), evaluation of interstrain synergism and contribution of protease 
and oxidoreductase systems of mono- and multistrain probiotics (symbiotics) and 
other type consortia, and identification of mosaics of complexes containing fluoro-
chromes in extended interval of pI/pH (complexes and cell wall fragments as carriers of 
visible energy which is ready for energetic exchange with surrounding infrastructures 
as well as for monitoring directed supramolecular assembling and their reorganization).
Aforementioned data presented develop other possible important prognostic 
approaches and proposals. The choice of wished prognostic (LSSM-selected-type 
and GC-type interactions)-directed events in biotope can be determined and 
regulated by involving GC types needed (panels of natural and artificial GC used in 
biotope; extending the list of GC indicated in Table 1 is possible). The use of artifi-
cial polymeric GC with established chemical structures allows receiving adequate, 
understandable, and reliable results.
According to the multifunctional potential of artificial GC used, resulting 
events in biotope can be the following ones: antipathogenic actions (the use of 
GC-imitating pathogenic cell surface structures), prebiotic and symbiotic (synbi-
otic) actions (the use of GC-imitating prebiotic structures), increasing own human 
organism protective systems (the use of GC-interacting and GC-regulating macro-
phages and macrophage-like lymphocytes through their systemic receptor lectins), 
antitumor actions (potential using antigenic GC together with LSSM as antagonists 
and synergists in intercellular antitumor and anti-infectious communications [37]), 
and cytokine lectin/lectin-like cascades initiated/regulated with LSSM potentially 
influencing redistribution of cytokine network in organism.
3.6 Prospects of LSSM for prophylaxis and therapy of infectious diseases
Innate immunity plays an important role especially when antibody immunity is 
under development, suppression, or alteration. So the search of new natural anti-
infectious agents is of actuality. In contrast to probiotic cells, LSSM (as systems of 
LL or LB) are not sensitive to the presence of antibiotics and chemotherapeutics as 
well as do not need special conditions for survival. LSSM function as metabolome-
biotics according to the principle “the network in the network”; participation of 
major lectins in supporting physiologically significant glycodecor of biotope muco-
sal probiotic compartments, and minor lectins—in signal communications; support 
of such compartments (compensation of the absence of probiotic cells in MB upon 
therapy with antibiotics, delivery of fucosylated and galactosylated prebiotics of 
mutual supporting influence between populations of bifidobacteria and lactobacilli, 
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body of pathogen) for the mostly effective visible actions of LS, obtaining uniform 
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cofunctioning to anti-infectious agents (antibiotics, metabiotics, GC) and cells of 
organism protective systems (macrophages and leukocytes).
We characterize LSSM (acidic, low acidic, cationic: aLL, laLL, cLL, aLB, and 
cLB) of domestic probiotics which recognize polymeric artificial GC mucin-like 
analogs of antigens and EPC (fungal and bacterial mannans, bifidobacterial α-L-
Fuc-containing, sulfated and phosphorylated).
Antimicrobial directions of LSSM action were established [26, 31, 38].
3.6.1 Anticandidosis activities
• Against intestinal and urogenital Candida of epidemiologically significant spe-
cies of group I (C. albicans and C. tropicalis: early action of aLB within the first 
2 days; delayed action of cLL and LB within 1–2 months; synergism between 
acidic and cationic LSSM, cLB, and grass lectins, aLSSM/cLSSM, and some 
antimycotics)
• Against Candida of epidemiologically significant species of group II (C. glabrata: 
inhibition of virulent factors such as fungal IgA1 and IgG proteinases, EC 3.4.21.72 
and EC 3.4.21., respectively [9])
• Against Candida of epidemiologically significant species of group III (C. krusei: 
delivery of potential effector GC on cell surface)
• Interruption of mycosymbiosis parasitism of Candida—Aspergillus: the drugs 
against candidosis as predictably affective against aspergillosis)
Activities of LSSM against staphylococci (on example of patients S. aureus 
isolates): aLL > aLB; aLL and aLB; LSSM activities accompanied with:
• Delayed degradation of microbial massifs
• Partial directed lysis of microbial massif
• Tearing away fragments of massif (by two mechanisms depending on lectin 
type)
• Synergism between aLL and LB in antistaphylococcal actions
LSSM possess potential of diagnostics and prognostics of biotope diseases [37]. 
Results support important principle approach that diseases of MB (as in the case of 
CBF according to the principle “there is the body—there are diseases”) reflect own 
“biotope diseases” in organism [39]. LSSM can be used in phenotyping prognostics 
and diagnostics of infectious processes in organism; for prophylaxis and therapy of 
candidoses, staphylococcoses, mixed fungal-bacterial infections, mixed symbiotic 
mycoses; innate infections; immunodeficiency and infections against the back-
ground of immunodeficiency, upon antibiotics-/chemo-/radiotherapy. Such GC 
effectors as metabiotics, prebiotics, glycoantigens, and drugs of selective directed 
action are of availability.
It is of importance to consider the participation of LSSM in supporting biotope 
mucosal MB in conditions of oxidative stress (cofunctioning of laLL and probiotic 
oxidoreductase systems) [26]. Panel combinations of LB and LL are perspective in 
early evaluation (before the inflammation) of status of MB of functionally different 
biotopes of the vaginal tract.
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LSSM are similar (in specificities, systemic action) to communicative lectins of 
intercellular reception in innate immunity.
LSSM act as essential part of human protective supersystem (the supersystem 
with probiotic type action) [31]. Such supersystems contract disturbing the balance 
of the body’s health processes; keep and maintain the integrity of biotope micro-
biocenoses like healthy consortia. There are supersystems with antimicrobial or 
antifungal action in organism.
3.7 Potential of results for innovations
Results obtained by us in a study of probiotics can be useful as a set of 
approaches in study of the following aspects of clinical microbiology and medical 
biotechnology (in brackets—significance and prospects of results for infectology) 
[40, 41].
3.7.1 Metabolite technologies
• Cultural metabolites 27–200 kD within pI 4–8 (separation of acidic and 
alkaline protein and nonprotein of taxonomically significant systems); phe-
notyping of strains in cationic region containing protected sets of proteins 
Subcytoagglutinating activities: initiatively coupled or non-coupled to lectin 
and cytoagglutinating activities (cytokine activities; synchronization of 
cultures for increasing vulnerability of pathogens; typing).
• Functional blotting analysis of cascade cultures in combinative nutrient 
media (NM) (as in the case of milk followed by transfer into “casein hydroly-
sate-yeast autolysate” media; monitoring lectins, enzymes, and exopolymeric 
compounds [EPC])
• Development of strain-supporting NM (comparison of blotted maps of 
components of cultures in identical conditions)
• The use of α-S-, β/γ-, and kappa-caseinases (increase of effectiveness of NM, 
accumulation of physiologically active protein and nonprotein metabolites and 
their complexes)
• Systems of proteinases, EPC depolymerases, and/or peroxidase-like catalases 
in cultures (revealing strain-dependent producers of enzymes, proteins, and 
EPC; evaluation of cytolysis populations, oxidative stress, virulent factors, 
changes, and aging of cultures upon passages and storage)
• Lectin systems: major and minor, building and signal, cross talk and quorum 
sensing (standardization of cultures and analysis of communicative networks) 
*Evaluation of early and prolonged landscape synergism of recognizing 
components of cultures and antibiotics (individual choice and replacement of 
combinations of probiotics and antibiotics upon therapy of patient)
• Natural and recombinant systems oriented to recognition of polyvalent glyco-
conjugate targets of known structure (standardization of strains; monitoring 
and revealing signals of carbohydrate metabolism)
• Imitation by cultural metabolites in respect to strain or consortium effective-
ness (standardization of strain multifunctionality)
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notyping of strains in cationic region containing protected sets of proteins 
Subcytoagglutinating activities: initiatively coupled or non-coupled to lectin 
and cytoagglutinating activities (cytokine activities; synchronization of 
cultures for increasing vulnerability of pathogens; typing).
• Functional blotting analysis of cascade cultures in combinative nutrient 
media (NM) (as in the case of milk followed by transfer into “casein hydroly-
sate-yeast autolysate” media; monitoring lectins, enzymes, and exopolymeric 
compounds [EPC])
• Development of strain-supporting NM (comparison of blotted maps of 
components of cultures in identical conditions)
• The use of α-S-, β/γ-, and kappa-caseinases (increase of effectiveness of NM, 
accumulation of physiologically active protein and nonprotein metabolites and 
their complexes)
• Systems of proteinases, EPC depolymerases, and/or peroxidase-like catalases 
in cultures (revealing strain-dependent producers of enzymes, proteins, and 
EPC; evaluation of cytolysis populations, oxidative stress, virulent factors, 
changes, and aging of cultures upon passages and storage)
• Lectin systems: major and minor, building and signal, cross talk and quorum 
sensing (standardization of cultures and analysis of communicative networks) 
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• Imitation by cultural metabolites in respect to strain or consortium effective-
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• The use of recognizing metabolites instead of cells or in combinations with 
cells for support of feeble living and antibiotic-sensitive cultures (also in cases 
of non-culturable microorganisms).
• Constructing balanced supporting MB of probiotic cell-metabolite consortia 
(constructing symbiotic consortia, balanced vaccines)
3.7.2 Intercellular and cell-metabolite technologies
• For Gram-positive bacteria (opportunistic and pathogenic)
• Sensor microbial systems of MB (revealing and using key antagonistic sys-
tems) Directed assembling of cytokine-cell gradients: reversible functional 
(1–2 days) or late irreversible conserved and partially inactivated (4–6 weeks), 
as in cases of biofilms containing erythrocytes—in microassay (evaluation of 
protection and degradation of human cells in the presence of pathogens)
• Biofilm forming as ranked quantitative and qualitative, early and delayed—in 
microassay (reactions of mono- and mixed biofilms)
• Species-dependent redistribution of antagonistic MB (prediction of mutual 
influence between species and strains of probiotics, opportunistic microbes, 
and antibiotics)
• Leader strains and species within MB (evaluation of temporary 
MB-destabilizing strains in coexistent antagonistic microbial populations)
• Destabilization and synchronization of MB by recognizing components of 
cultures for increasing future selective synergistic action of antimicrobi-
als and stress factors (increase of early and late suppression of pathogens) 
Microecological interniche early and delayed landscape relationships in cases 
of solid-phased and suspension microbial massifs, for microanalysis (evalua-
tion of opportunistic microbes and MB as communicative bodies opposed to 
mosaics of antimicrobials)
• Construction of active (involving probiotic leaders) and stabilizing (species-
dependent and resistant to antibiotics, probiotic-like supporting MB) consortia 
(using upon therapy)
• Strain-phenotyping dysbiotic MB using lectin systems (revealing early changes 
in patient MB in the presence of lectins of MB, for development of new strate-
gies of therapy)
• LS of probiotic consortia (directions of consortium formula actions can be pre-
dicted by constructing) as ingredients of functional food to support resistant 
functioning mucosal organs
4. Conclusion
The data presented consider aspects of constructing probiotic multistrain 
intra- and inter-genus Gram-positive bacterial metabolites on examples of 
bifidobacteria and lactobacilli of the human gut origin. Algorithms of creation 
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of 4- and 7-code MP formulas are presented and argued. It is of importance to 
consider LSSM and their GC as a new perspective protective basis/scaffold factor 
influencing and supporting human interactome, involving biotope infrastructures, 
signaling, and anti-infectious actions as well as cofunctioning together with other 
protective human systems [17, 42]. Results support the use of pro-/symbiotic LS 
as assistant-coordinated metabolomic agents; carriers for delivery and releasing 
GC, metabiotics (including simulators of cell surface patterns of opportunistic 
microorganisms), prebiotics, therapeutics, and antigens (for cofunctioning to 
antibodies); and reserves for decoration elements that support stabile function-
ing landscapes of the human cell surfaces and mucosal tissues. Probiotic lectins 
(interacting with synthetic GC simulators) are important for screening, typing, 
and selection of useful strains and their consortia supporting organs. The proposed 
LSSM-containing preparations promise LSSM using a soft adaptive multidirected 
network synergistically acting together with other protectors (also in conditions of 
the absence of oxygen [involving oxidative stress and forming of covalently bound 
by-products] within biotope). Variants of multipro-/sym-/synbiotics constructed 
can be perspective for prophylaxis for individuals and contingents as well as for 
supporting treatments of patients (before and postoperative period, during chemo-
therapy, etc.). Approaches developed are useful in study of interniche relationships 
of extended set of Gram-positive and fungal microorganisms in mono- and mixed 
cultures. Procedures can be applied in different fields of clinical microbiology and 
medical biotechnology.
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Abstract
Malnutrition through excessive food consumption is a worldwide pandemic. 
Changes in lifestyle, diet and physical activity have resulted in an exponential 
increase in the number of obese people around the world. Multiple factors influence 
the development of this disease, and recently it has been suggested that gut micro-
biota (GM) plays an important role in nutrient absorption and energy regulation 
of individuals, thus affecting their nutritional status. It has been proven that gut 
microbiota is different in individuals with a normal nutritional status compared 
to those who are obese. Therefore, to study bacterial populations that make up the 
microbiota and to understand how prebiotics and probiotics affect the increase 
of these bacteria has become a promising alternative to treat obesity. This chapter 
looks at defining the established relationship between probiotics, prebiotics and gut 
microbiota that develop in obese people and people of normal weight, with the aim 
of providing future dietary recommendations to treat this medical condition.
Keywords: gut microbiota, prebiotics, probiotics, obesity
1. Introduction
Currently, obesity is defined as a medical condition characterised by an energy 
imbalance as a consequence of energy intake bigger than energy expenditure [1]. 
The US Centers for Disease Control and Prevention (CDC) defines it as ‘excessive 
weight that is considered unhealthy for a given height’. It was not until 1997 that the 
World Health Organization (WHO) described obesity as an excessive accumulation 
of body fat that can be harmful to people’s health [2].
One of the criteria to diagnose obesity is through the calculation of body mass 
index (BMI); the result, according to the WHO, must be equal to or bigger than 
30 kg/m2 [2].
However, the Asian population including Korea, given their increased risk of 
developing comorbidities, such as cardiovascular diseases and type 2 diabetes, 
agreed to an overweight category with a BMI between 23 and 24.9 kg/m2 and 
obesity with a BMI > 25 kg/m2 (Table 1) [3].
Worldwide obesity is a public health problem, and despite all the strategies 
designed and implemented to reverse the situation, these have not been effec-
tive. According to the World Health Organization, globally, in 2016, more than 
93
Chapter 6
Gut Microbiota and Obesity: 
Prebiotic and Probiotic Effects
Silvana Cisternas León, Paula Carrasco Vergara,  
Alejandra Cruz Neira, Ricardo Muñoz Maldonado,  
Carolina Díaz Araneda and Marcia Rivas Zuñiga
Abstract
Malnutrition through excessive food consumption is a worldwide pandemic. 
Changes in lifestyle, diet and physical activity have resulted in an exponential 
increase in the number of obese people around the world. Multiple factors influence 
the development of this disease, and recently it has been suggested that gut micro-
biota (GM) plays an important role in nutrient absorption and energy regulation 
of individuals, thus affecting their nutritional status. It has been proven that gut 
microbiota is different in individuals with a normal nutritional status compared 
to those who are obese. Therefore, to study bacterial populations that make up the 
microbiota and to understand how prebiotics and probiotics affect the increase 
of these bacteria has become a promising alternative to treat obesity. This chapter 
looks at defining the established relationship between probiotics, prebiotics and gut 
microbiota that develop in obese people and people of normal weight, with the aim 
of providing future dietary recommendations to treat this medical condition.
Keywords: gut microbiota, prebiotics, probiotics, obesity
1. Introduction
Currently, obesity is defined as a medical condition characterised by an energy 
imbalance as a consequence of energy intake bigger than energy expenditure [1]. 
The US Centers for Disease Control and Prevention (CDC) defines it as ‘excessive 
weight that is considered unhealthy for a given height’. It was not until 1997 that the 
World Health Organization (WHO) described obesity as an excessive accumulation 
of body fat that can be harmful to people’s health [2].
One of the criteria to diagnose obesity is through the calculation of body mass 
index (BMI); the result, according to the WHO, must be equal to or bigger than 
30 kg/m2 [2].
However, the Asian population including Korea, given their increased risk of 
developing comorbidities, such as cardiovascular diseases and type 2 diabetes, 
agreed to an overweight category with a BMI between 23 and 24.9 kg/m2 and 
obesity with a BMI > 25 kg/m2 (Table 1) [3].
Worldwide obesity is a public health problem, and despite all the strategies 
designed and implemented to reverse the situation, these have not been effec-
tive. According to the World Health Organization, globally, in 2016, more than 
Oral Health by Using Probiotic Products
94
1900 million adults were overweight, over 650 million were obese, and 41 million 
children under the age of 5 were overweight. Fifty-seven percent of the world’s 
population lives in countries where being overweight and obesity cause more deaths 
than being underweight. Furthermore, each year at least 2.8 million people die 
worldwide due to obesity or being overweight, irrespective of whether the country 
is economically developed or not [1, 2].
Various studies have shown that patients with illnesses related to the gastroin-
testinal tract, such as type 2 diabetes, obesity and cardiovascular diseases, among 
others, present dysbiosis or an imbalance within the gut microbiota (GM).
A hypothesis of the positive influence of microbiota on fat storage exists, and 
several studies carried out in mice have proven the role of certain fatty acids in the 
diet in the prevention of obesity, an effect mediated through changes in the compo-
sition of gut microbiota. Studies in humans have also shown a relationship between 
a decrease in Bacteroidetes in obese individuals and a greater proportion of these in 
the faecal microbiota in subjects who have undergone hypocaloric diets and who 
have managed to reduce their weight [5, 7].
An important role of the regulation of gut microbiota has been proven as the 
ingestion in the diet of prebiotics and probiotics that modulate the growth of 
diverse families of bacteria that could influence the nutritional status of individuals.
2. Obesity as a multifactorial condition
Obesity is a medical condition of multifactorial causes, ranging from the influ-
ence of the nearby environment on the acquisition of predisposing habits, such 
as the consumption of foods high in refined carbohydrates and saturated fats and 
a sedentary lifestyle. Genetic predispositions are also among the principle causes 
[5]. On the other hand, socioeconomic development, transport, urban planning, 
environmental, agricultural, educational, processing, distribution and marketing 
policies on food influence dietary habits and preferences, as well as people’s level of 
physical activity [5, 6].
Research concludes that obesity occurs with greater prevalence in women, older 
people (25 years and above), those with a lower school level and those with a low 
socioeconomic income. Geographic location also has an influence, but it occurs in an 
opposite way in men and women. There is greater obesity in women living in rural 
areas, but in men rurality is a protective factor since obesity is more prevalent in those 
living in urban areas. This is most likely explained by the higher levels of physical 
activity of men living in rural areas [6]. In terms of lifestyles, obese people have lower 
levels of physical activity, a bigger consumption of salt and low levels of sleep [7].
Another bibliographical review relates meal times with the prevalence of 
obesity. This study, which is based on an analysis of the circadian rhythm, a biologi-
cal function regulated by the anterior hypothalamus, reveals clinical observations 






Comparison of the World Health Organization (WHO) and Asia-Pacific body mass index (BMI) 
classifications in COPD patients [3].
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and experiments on animals that relate the times of food intake to metabolism and 
body weight. It is proposed that eating at times when the body is prepared for rest 
increases body weight. At rest there are low levels of hormonal activity, a low body 
temperature and low activity of nutrient absorption which alters energy homeosta-
sis and facilitates the accumulation of energy, increasing body weight [5, 8].
A factor recently studied as a cause of obesity is gut microbiota, defined as the 
communities of living microorganisms that colonise the intestines. It is known 
that the gut microbiota contributes significantly to the two main functions of the 
gastrointestinal tract: nutrition and defence.
3. Human gut microbiota: role in people’s health
The human gut is colonised by an enormous quantity of communities of living 
microorganisms, mainly bacteria that form the GM. As well as participating in 
processes of digestion and absorption of nutrients, the homeostasis of GM has been 
linked to beneficial health effects [9].
In the womb, the intestine of the human foetus is sterile, and it is after birth 
when the newborn acquires its gut microbiota. From birth, several factors influ-
ence the composition and initial colonisation of the GM. Natural labour favours the 
rapid settlement of bacteria that come from the vaginal and faecal microbiota of 
the mother, associated with a low risk of suffering from diseases and some types of 
malnutrition through excessive food consumption in the future. On the other hand, 
children born through caesarean section have a slower colonisation of bacteria, 
mainly from the hospital environment and healthcare professionals who are in con-
tact with the child. It must be considered that the time taken to establish the GM is a 
risk factor for the colonisation of Clostridium. Despite the fact that GM is established 
from birth, its colonisation continues to vary, given that there are diverse factors that 
influence its composition: nutrition, exclusively or predominantly breastfeeding, 
age, geographic location and intake of supplements and medicines [9, 10].
In the first years of life, when nutrition is acquired through breastfeeding or 
formula milk, GM is mostly populated by bifidobacteria. This is highly adapted to 
processing oligosaccharides in milk. Later, reaching adulthood, the GM is made 
up of two main families of bacteria: Firmicutes and Bacteroidetes. Firmicutes are the 
family found in greater proportion, including more than 200 genders, and the most 
important are Mycoplasma, Bacillus and Clostridium. Once these are established in 
adulthood, they remain stable in the individual (Figure 1) [11–14].
Various studies support the fact that variations in people’s health status are 
directly related to functions of the GM, highlighting its effect on the immune 
response, nutrition and metabolism [15].
The immune tissues of the gastrointestinal tract make up the most complex and 
largest proportion of the body’s immune system, which is why alterations of GM 
are caused by disequilibrium of the immune system, such as the development of 
allergies and autoimmune diseases [16].
There is a complex interaction between the microbiota, the intestinal epithelium 
and the gastrointestinal immune system, with many metabolites and microbial 
components that have a direct influence on the host immunity. The production of 
metabolites from nutrients or the modification of the metabolites produced by the 
host has a direct effect on the immune cells and on the integrity and permeability of 
the intestinal epithelium. The enteric immune system is constantly evaluating and 
responding to the gut microbiota [17].
Nutritional and metabolic functions of GM involve the synthesis of certain 
vitamins such as K, B12, biotin, folic acid and pantothenic acid, as well as the 
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fermentation of non-digestible carbohydrates, polysaccharides and oligosaccha-
rides. It makes up an important source of energy for bacterial proliferation and 
produces short-chain fatty acids that the host can absorb, favouring the recovery 
and absorption of ions such as calcium, iron and magnesium [18].
As well as the principal functions of GM, recent studies have associated it with 
the development of obesity and chronic diseases. In order to avoid such conditions, 
it has been proposed that the role of prebiotics and probiotics in the maintenance of 
the nutritional status and prevention of diseases should be studied [4].
Undoubtedly, microorganisms present in the guts are fundamental throughout 
life as they have a direct relationship with health and illness. It is vital to take special 
care in the factors that make up the initial GM as it is responsible for the general 
status of future health of individuals.
4. Microbiota and its role in obesity and chronic diseases
As already described, the gut microbiota is made up of a diversity of pathogens 
which highlights the presence of Gram-negative or Gram-positive bacteria. The 
equilibrium of this ecosystem provides us great health benefits, in the absorption 
and digestion of nutrients, as well as influencing immune function [4–18].
In recent years, the prevalence of non-transmittable chronic diseases has 
increased, which has led different researchers to address the different risk factors 
related to the appearance of those that have been mentioned and the direct risk 
between microbiota and diseases [18].
Studies linked to the establishment of microbiota with chronic diseases have 
described that this stability of original microbiota is affected by diverse factors 
among which the macro- or micronutrients and dietary patterns are mentioned [18].
When the balance of microbiota is altered by a factor, whether it is the use of 
antibiotics, stress or diet with an increased consumption of fats, carbohydrates and 
fibre, it will have an effect on health. It has also been mentioned that abundance 
or scarcity of food, environmental pollution, chronic stress and food such as dairy 
products, sugars, coffee, tea and alcohol, among others, affects the intestinal 
mucous membrane and, consequently, changes the stability and mode of action of 
the microbiota [19].
All these factors cause an alteration in microbiota where the equilibrium of 
two large families of bacteria is affected: Bacteroidetes and Firmicutes. In a study 
carried out on the composition of the microbiota of obese mice, it was shown that 
they had increased concentrations of Firmicutes by more than 50%, while those of 
Bacteroidetes decreased correlatively [20].
Figure 1. 
Factors that influence the initial colonisation of gut microbiota.
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In order to demonstrate that the microbiota changes through time, a study 
was carried out where old teeth found in skeletons in different periods of history 
were analysed. It was found that microbial changes are linked to human evolution 
from the hunter-gatherer period to the industrial revolution, due to the increased 
consumption of processed foods. These conclusions support the idea that diet and 
the type of food alter human microbiota [18].
Turnbaugh et al. carried out studies on ‘humanised’ or sterile mice models to 
which human faecal matter was transplanted and the microbiota was analysed once 
they were fed with a Western diet rich in fats and sugars. They found a presence of 
greater adiposity and a reduced proportion of Bacteroidetes than Firmicutes in the 
faecal microbiota of these mice [19].
There is a direct relationship between microbiota and energy uptake and 
consequently a relationship with the onset of obesity. This has been supported by 
a study in obese children, which showed a microbiota rich in Enterobacteriaceae, 
low in Bacteroidetes and increased in Firmicutes. When the children were subjected 
to diets with low carbohydrate and fat content, the composition of the microbiota 
changed [18].
Other studies carried out in mice reflect the relationship between energy bal-
ance, diet and microbiota. The transplantation of the obese microbiota results in an 
increase of adiposity in the recipients, which shows that microbiota affects nutrient 
acquisition, energy storage and consequently the development of obesity [18, 22].
Jumpertz et al. carried out studies on the GM of obese and slim patients. They 
were given caloric diets, and their stools were analysed by measuring calories 
ingested and those eliminated in the faeces using a bomb calorimeter. This study 
concluded that there are changes in the GM where there are increases in energy 
storage, a decrease in the Bacteroidetes and an increase in the Firmicutes bacteria. All 
these changes could explain the variation of the uptake of energy in individuals and 
therefore a relationship with the predisposition to obtain metabolic disorders [18].
According to the above, the instability of the GM or changes in the original GM 
affects the metabolism of the whole organism. Recent studies have shown that the 
increase of bile acids in the intestine when comparing sterile rats with normal rats 
would show that the GM is not only related with obesity but also with a diverse 
range of metabolic diseases [21].
When transplanting GM into obese mice, the new term obesogenic microbiota 
was determined, associated with an increase in hepatic glucose production and 
promotion of triglyceride deposits. These studies show that there is an increase in 
TNF pro-inflammatory cytokines which can cause insulin resistance. This can be 
correlated with the appearance of DM-OB, since its presence has been proven to be 
directly related to the presence of elevated pro-inflammatory factors [22].
Toll-type receptors are receptors that recognise important patterns within immu-
nity and inflammation processes; they are present in diabetic obese patients with 
metabolic syndrome. In publications made in the Latin American report, they show 
the role of GM with regard to the regulation of these diseases, since the mice deficient 
in Toll-like receptor 5 (TLR5), which recognises microbial patterns, show hyperpha-
gia, become obese and develop characteristics indicative of metabolic syndrome. This 
is also proven when GM from these mice was transplanted into germ-free mice with 
the TLR5 gene—the receptor mice developed characteristics similar to the metabolic 
syndrome. In summary, Larsen et al. demonstrated that GM from diabetic patients 
produced a significant reduction in Firmicutes and Clostridia [22, 23].
When administering antibiotics to these types of obese patients, many Firmicutes 
were eliminated, which resulted in improved insulin and glucose intolerance.
The exact mechanisms by which GM contributes to the development of obesity 
have not been fully elucidated, but it has been suggested that the main ways would 
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include increased lipoprotein lipase (LPL) activity, increased intestinal permeabil-
ity and lipogenesis [20]. Faecal microbiota transplantation studies in both healthy 
individuals and rats to obese receptors have shown the favourable action of the 
GM of the emitters towards the obese individuals, reducing the levels of glycemia, 
preventing the expansion of fat and regulating inflammatory processes. Studies also 
suggest that the reverse mechanism, that is, transplantation of intestinal microbiota 
from obese to healthy individuals, can transmit the development of obesity, assign-
ing GM as a predisposing factor for obesity [17].
Thanks to many randomised studies that have been carried out, it will be pos-
sible to identify the microbiota properties that are contributing to the obesity epi-
demic, diabetes and metabolic diseases. This will in turn allow scientists to extract 
information and characterise diseases with the aim to prevent or cure them [21].
5. Role of prebiotics and probiotics in maintaining nutritional status
Probiotics have been defined by the United Nations’ Food and Agriculture 
Organization (FAO) and the WHO as ‘living microorganisms that provide their host 
with health benefits when consumed in appropriate quantities’ [4].
Prebiotics were defined by Gibson and colleagues in 2004 as ‘ingredients that 
when selectively fermented, give rise to specific changes in gut microbiota com-
position and/or activity, which leads to many health benefits with regard to, for 
example, the wellbeing of individuals’ [24].
According to the preceding analysis, it has been recently established that the 
microbiotics that colonise the human intestine can play an important role in causing 
obesity and developing other metabolic and immunological illnesses within their 
host. This statement is based on recent metagenomic studies that have determined 
that there are differences between obese individuals and those of a normal weight 
in terms of gut microbiota. These differences are associated with the presence of a 
microbial population in obese individuals, which has a greater capacity to recuper-
ate dietary energy and/or favour the onset of chronic low-grade inflammation [25].
Some studies conducted on obese individuals in relation to their prebiotic 
 consumption—capable of selectively stimulating a limited number of gut microbi-
ota genres/species which results in health benefits—have demonstrated results that 
can be categorised by an increasing trend in satiation. This effect has been observed 
with inulin fibre [24].
The mechanisms implicated in satiation following the consumption of oligofruc-
tose and inulin have been associated with intestinal fermentation-induced hydrogen 
formation, which in turn has been correlated with a postprandial increase in 
plasma levels of peptides GLP-1 and PYY, which are involved in energy homeostasis 
through supressing the sensation of hunger (Figure 2) [24].
Studies carried out involving the use of probiotics to control body fat accu-
mulation show promising results, but it is also necessary to carry out further, 
well-designed studies which incorporate randomised, double-blind trials with a 
placebo control, in order to demonstrate the efficacy of specific probiotic strains 
when preventing or treating the overweight and obese. In this sense, it is important 
to highlight that the results obtained in the trials would be specific to the strains 
analysed, meaning it is not possible to extrapolate the results or action mechanisms 
to a species or genre as a whole [4, 24].
Consequently, much remains to be done in this field. However, when putting 
everything in perspective, modulating the composition of gut microbiota using 
probiotics could be considered as a new avenue through which we can treat the 
overweight and obese [24].
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On the other hand, prebiotics promote the absorption of minerals such as 
calcium, magnesium, zinc and iron due to their ability to bind to them. This thereby 
prevents their absorption into the small intestine to reach the colon, where they 
are released and subsequently absorbed. Better calcium absorption is linked to 
prebiotic fermentation caused by gut microbiota, which produces short-chain fatty 
acids and lowers luminal pH, increasing the bioavailability and passive absorption 
of calcium through colonocytes. It has also been proven that calcium bioavailabil-
ity is improved when released through hydrolysis of a compound called ‘calcium 
phytate’, which occurs due to action of bacterial phytases present in the beneficial 
microbiota. It is also improved when calcium becomes more soluble as a result of an 
increase in the volume of water in the colon, caused by the osmotic effect of prebi-
otics. This increase in calcium absorption is beneficial for bone health as it increases 
bone mass and delays the onset of osteoporosis. This is important when considering 
growth periods, during which peak bone mass is reached in postmenopausal women 
and in elderly people [25].
Prebiotics stimulate iron absorption into the colon, by increasing the soluble frac-
tion in the cells. Zinc is necessary for the development and maturation of the skele-
ton, and prebiotics stimulate zinc bioavailability. Therefore, mineral is supplemented 
through the diet. Furthermore, prebiotics are attributed to another set of properties 
related to particular systemic disorders. Prebiotic carbohydrates (GOS, FOS, inulin) 
reduce blood pressure, as well as blood levels of glucose, cholesterol, triglycerides and 
phospholipids, as well as triglyceride and fatty acid synthesis in the liver, minimising 
the risk of developing diabetes, obesity and atherosclerosis [25, 26].
6. Influence of probiotics in the development of obesity
The development of obesity is not caused by one specific factor. On the contrary, 
it is the result of an interaction of genetic, environmental, social, lifestyle factors, 
etc., which transforms it into a multifactorial disorder, which explains how quickly 
it has become more prevalent throughout all age groups in developed countries and 
shows that traditional theories are not adequate to explain the complex phenom-
enon of gaining body weight [27].
In recent decades and as a result of advances in science, research for ‘nontradi-
tional’ etiological factors involved in an individual’s excessive weight gain has begun 
[28]. One of these new factors is highlighted in a study on the role of probiotics and 
their influence on gut microbiota. It should be noted that even now few studies have 
been carried out on humans to elucidate the effect of these microorganisms on body 
Figure 2. 
Mechanisms implicated in the satiety of obese individuals related to inulin consumption.
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include increased lipoprotein lipase (LPL) activity, increased intestinal permeabil-
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Prebiotics were defined by Gibson and colleagues in 2004 as ‘ingredients that 
when selectively fermented, give rise to specific changes in gut microbiota com-
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host. This statement is based on recent metagenomic studies that have determined 
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with inulin fibre [24].
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Studies carried out involving the use of probiotics to control body fat accu-
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well-designed studies which incorporate randomised, double-blind trials with a 
placebo control, in order to demonstrate the efficacy of specific probiotic strains 
when preventing or treating the overweight and obese. In this sense, it is important 
to highlight that the results obtained in the trials would be specific to the strains 
analysed, meaning it is not possible to extrapolate the results or action mechanisms 
to a species or genre as a whole [4, 24].
Consequently, much remains to be done in this field. However, when putting 
everything in perspective, modulating the composition of gut microbiota using 
probiotics could be considered as a new avenue through which we can treat the 
overweight and obese [24].
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weight, and existing studies still show contradictory results; the available literature 
arises from findings found in animals (rats) [4].
However, several ways in which probiotics may influence adiposity and weight 
gain have been identified. These range from extracting calories from nutrients, 
generating specific metabolites, to modulating the behaviour of the brain-intes-
tine axis [27].
These hypotheses arise from research suggesting that obese individuals have a 
different composition of gut microbiota to subjects of a normal weight. For exam-
ple, in people with obesity, they have observed a decrease in members of phylum 
Bacteroidetes (Prevotella and Bacteroides genera) and an increase in members of phy-
lum Firmicutes (Clostridium, Enterococcus, Lactobacillus). It has been suggested that 
the aforementioned microorganisms have a greater capacity to extract energy from 
the undigestible waste products of nutrients that pass through the large intestine. 
These alterations are normalised with both phyla, when the subjects lose weight 
(increase of Bacteroidetes and decrease of Firmicutes) [29]. It has been observed that 
obese and inactive people have greater adiposity and insulin resistance but also less 
diversity and microbial composition (Figure 3) [4].
A study conducted at Laval University in Canada evaluated the effect of 
Lactobacillus rhamnosus probiotic (LRP) supplementation on weight reduction, 
appetite control and eating behaviour in a group of obese men and women. The 
results showed that, in the group of women, the consumption of this microorgan-
ism provides beneficial effects on mood and behaviour linked to dietary intake, 
compared to the group of men and those who received the placebo. This opens up 
a series of possibilities for health professionals with regard to the implementation 
of successful obesity programmes, especially considering that many individuals 
experience great difficulties when trying to sustain their weight loss. This is mainly 
due to poor appetite control and not taking the necessary action to lead a healthy 
lifestyle. Based on the findings of this research, it has been suggested that some 
probiotic strains could be included as environmental factors with regard to body 
weight loss and maintenance [27].
Corroborating these findings, a multicentre, randomised, double-blind study 
conducted on 29 men and 14 women, using the microorganism Lactobacillus gasseri 
and administered through a probiotic yogurt for 12 weeks, demonstrated, in the 
individuals analysed, a 4.6% decrease in areas of abdominal and subcutaneous fat, 
as well as a decrease in BMI, waist and hip circumference [4].
Nevertheless, and contrary to these results, several investigations using a similar 
model maintain that administering yogurt with other species of probiotics such as 
Figure 3. 
Gut microbiota imbalance between healthy and obese individuals.
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Bacillus lactis Bb 12 and Lactobacillus acidophilus La5 has no effect on body weight, 
BMI and serum lipid levels. This is also the case with Streptococcus thermophilus in 
fermented milk for 8 weeks [4].
As previously mentioned, the impact of consuming probiotics in relation to 
obesity and a variety of parameters has been widely documented. This is, thanks to 
studies on rats, used when administering different strains of the Lactobacillus and 
Bifidobacterium genera; various hypotheses have emerged from these investiga-
tions. More specifically, one of these arose from observing axenic mice (without 
gut microbiota). Despite consuming 30% more food than conventional animals 
of the same age and weight, they have 42% less total body fat. However, once the 
microbiota from conventional mice was transplanted into the digestive tract of the 
axenic mice, these latter experienced a 57% increase in total body fat. The mecha-
nism associated with this increase is linked to the increased activity of the enzyme 
lipoprotein lipase, which inhibits the fasting-induced adipocyte factor (FIAF) 
hormone due to the effect of the gut microbiota. This explains why axenic mice do 
not show weight gain even when consuming a high-calorie diet. Various studies 
carried out on rats show that the ‘antiobesity’ effect is determined by differences 
between microbial species and strains [20].
There is not much research on the effect of probiotics and their relationship 
with obesity; however, the findings that are available indicate that the changes 
caused by gut microbiota could be useful as another strategy in the current quest to 
combat obesity. However, it is necessary to continue researching in this area, with 
more emphasis on investigations on humans and populations with a representative 
number of subjects so that results can be valid and extrapolated.
7. Discussion
Currently, obesity is a major public health problem worldwide. There is no spe-
cific cause that determines the development of this disease; on the contrary, it is the 
result of numerous factors that interact, including genetic, environmental, food, 
lifestyles, etc. [27]; however, the study of intestinal microbiota and its implication 
in obesity has aroused curiosity among scientists. The current information obtained 
comes mainly from the work done in rats and, exceptionally, in humans [17].
Although much of the research indicates that there are differences in the com-
position of the intestinal microbiota of obese and normal subjects, there is still 
controversy about it [4].
As indicated in this chapter, the development of these intestinal bacterial com-
munities depends to a large extent on the host and can be modified by exogenous 
and endogenous influences. Ghosh et al. in 2011 talked about the direct relationship 
between food patterns and the microbiota composition [18].
In 2013, Devaraj et al. established the existing association in the imbalance of 
the microbiota where the composition of this is affected producing an increase 
of the Firmicutes genus and a decrease of the Bacteroidetes; this instability would 
affect the metabolism of the human being and as a consequence the appearance of 
various metabolic diseases among which obesity stands out [21]. In the same way, 
several publications continue confirming this situation, for example, the study of 
Jameel Barkat of the year 2018 relates the role of the microbiota in the regulation of 
energy balance, food absorption and its relationship with the appearance of various 
diseases: diabetes, metabolic syndrome and obesity, among others [30]. A study 
was conducted in 36 adults analysing the faecal bacterial composition, finding a 
decrease in Firmicutes and Clostridia in diabetic patients compared to the control 
group. This same research reaffirms that among the factors that alter the stability 
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and composition of the microbiota are the changes in the diet (high-fat diets) that 
impact on the relationship between Firmicutes and Bacteroidetes [31].
In order to demonstrate the aforementioned, it is convenient to point out two 
investigations carried out in 2015; Kasai et al. [32] conducted a study in Japanese 
population where they observed that bacterial diversity was significantly higher in 
obese subjects than in nonobese subjects. In the first group, there was a decrease of 
the Bacteroidetes species and increase of Firmicutes [31]. Angelakis et al. showed in 
a study performed in thin and obese subjects that the Firmicutes and Actinobacteria 
genera were the most predominant of the duodenal microbiota; however, in subjects 
with obesity, a higher proportion of anaerobic and lower proportions of aerobic 
genus were observed [33].
On the other hand, there are other authors such as Murugesan et al. that indicate 
in a study carried out in 190 Mexican children between 9 and 11 years old no signifi-
cant differences between the different bacterial species of microbiota in the differ-
ent evaluated subjects [34]. The same happens in Hu et al. In 2015, when 134 Korean 
adolescents from 13 to 16 years old were evaluated, no significant differences were 
found between the Bacteroidetes, Firmicutes and Proteobacteria populations [35].
It is widely recognised in the scientific community that diets with high-fat 
content favour the development of resistance to leptin, hyperphagia and therefore 
obesity. A study points out that the inclusion in the diet of the oligofructose prebi-
otic prevents the development of resistance to leptin and hyperphagia in rats; from 
this it is concluded that oligofructose reduces the energy of ingestion, and therefore 
it is suggested that it has the potential for the obesity treatment [36].
On the other hand, the use of probiotics is associated with multiple health ben-
efits, which are highly endorsed by the scientific community. So far, the data that 
associate a specific type of microorganisms with human obesity are not conclusive, 
since they do not say whether it is the microbiota that plays a cause-effect function 
of obesity or whether it is the intestinal microbiota that is modulated in response 
to obesogenic diets and other factors related to the pathogenesis of this condition 
[28–30, 37].
Studies aimed at modulating the gut microbiota to prevent or control the obesity 
of the host, including the use of probiotics, show positive results [25, 30].
With the reviewed bibliographic evidence, it is crucial to highlight the impor-
tance of including the gut microbiota as one of the factors involved in the manage-
ment of obesity; however, more conclusive information must be analysed about it 
evaluating what happens even in other specific groups such as the child population.
8. Conclusions
As has been discussed in this chapter, multiple factors influence the develop-
ment of obesity, including diet, a sedentary lifestyle, selection and an inadequate 
intake of nutrients such as simple carbohydrates and saturated fats. It has also been 
observed that obese individuals and those of a normal weight have different com-
positions of gut microbiota, with some bacterial families more predominate than 
others, which in turn modulates an individual’s energy balance in some way and 
promotes the development of obesity. It has been established that a dietary supply 
of prebiotics and probiotics, for which there is scientific evidence demonstrating 
their benefits, could serve as an additional tool to curb the rising trend of obesity in 
the population.
However, more studies using randomised, double-blind, controlled trials are 
necessary to demonstrate the efficacy of prebiotics and probiotics for the preven-
tion or treatment of overweight and obesity.
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